Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
10000,,,13487530,[],CHEMBL2438932,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924757,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10001,,,13487539,[],CHEMBL2438933,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924757,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10002,,,13501719,[],CHEMBL2446540,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 12-6 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
10003,,,13501730,[],CHEMBL2446541,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 12-5 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
10004,,,13501741,[],CHEMBL2446542,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-14 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
10005,,,13501752,[],CHEMBL2446543,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-10 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
10006,,,13501763,[],CHEMBL2446544,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-8 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
10007,,,13502960,[],CHEMBL2446545,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-4 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
10008,,,13502971,[],CHEMBL2446546,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
10009,,,13502982,[],CHEMBL2446547,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 11-2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
10010,,,13502993,[],CHEMBL2446548,Antibacterial activity against erythromycin-sensitive Streptococcus pyogenes ATCC 19625 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
10011,,,13503004,[],CHEMBL2446549,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-11 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
10012,,,13503015,[],CHEMBL2446550,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-4 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
10013,,,13503026,[],CHEMBL2446551,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-5 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
10014,,,13503037,[],CHEMBL2446552,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 11-20 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
10015,,,13503048,[],CHEMBL2446553,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
10016,,,13503059,[],CHEMBL2446554,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-31 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10017,,,13503070,[],CHEMBL2446555,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-32 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10018,,,13503081,[],CHEMBL2446556,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928126,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10019,,,13798056,[],CHEMBL3039491,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,1937411,=,1,1,=,,Inhibition,%,,60.1,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,Inhibition,%,UO_0000187,,60.09501418
10020,,,13798625,[],CHEMBL3039492,pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,5.23,0,http://www.openphacts.org/units/Nanomolar,1937411,=,1,1,=,,IC50,nM,,5888.44,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,pIC50,,UO_0000065,,5.23
10021,,,13800070,[],CHEMBL3039488,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,1937411,=,1,1,=,,Inhibition,%,,62.01,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,Inhibition,%,UO_0000187,,62.01396002
10022,,,13800624,[],CHEMBL3039489,pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,5.46,0,http://www.openphacts.org/units/Nanomolar,1937411,=,1,1,=,,IC50,nM,,3467.37,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,pIC50,,UO_0000065,,5.46
10023,,references out of a total of 4,14000651,[],CHEMBL3137722,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (moderate),,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),,,,4.0
10024,,,14000652,[],CHEMBL3137723,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,1980107,=,1,0,=,,Hepatotoxicity (moderate),%,,1.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),%,UO_0000187,,1.8
10025,,references out of a total of 4,14000653,[],CHEMBL3137724,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (acute),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (acute),,,,0.0
10026,,,14000654,[],CHEMBL3137725,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,1980107,=,1,0,=,,Hepatotoxicity (acute),%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (acute),%,UO_0000187,,0.0
10027,,references out of a total of 4,14000655,[],CHEMBL3137726,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (cytolytic),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cytolytic),,,,0.0
10028,,references out of a total of 4,14000656,[],CHEMBL3137727,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (choleostasis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (choleostasis),,,,0.0
10029,,references out of a total of 4,14000657,[],CHEMBL3137728,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (severe hepatitis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (severe hepatitis),,,,0.0
10030,,references out of a total of 4,14000658,[],CHEMBL3137729,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (chronic liver disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (chronic liver disease),,,,0.0
10031,,references out of a total of 4,14000659,[],CHEMBL3137730,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (cirrhosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cirrhosis),,,,0.0
10032,,references out of a total of 4,14000660,[],CHEMBL3137731,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (granulomatous hepatitis),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (granulomatous hepatitis),,,,0.0
10033,,references out of a total of 4,14000661,[],CHEMBL3137732,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (association with vascular disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (association with vascular disease),,,,0.0
10034,,references out of a total of 4,14000662,[],CHEMBL3137733,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (steatosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (steatosis),,,,0.0
10035,,references out of a total of 4,14000663,[],CHEMBL3137734,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (malignant tumour),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (malignant tumour),,,,0.0
10036,,references out of a total of 4,14000664,[],CHEMBL3137735,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,=,1,0,=,,Hepatotoxicity (benign tumour),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (benign tumour),,,,0.0
10037,,,14000665,[],CHEMBL3137736,Animal toxicity known. [column 'TOXIC' in source],T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,,1,0,,,Hepatotoxicity (animal toxicity known),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (animal toxicity known),,,,
10038,,,14000666,[],CHEMBL3137737,Presence of at least one case with successful reintroduction. [column 'REINT' in source],T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,,1,0,,,Hepatotoxicity (successful reintroduction),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (successful reintroduction),,,,
10039,,,14000667,[],CHEMBL3137738,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,,1,0,,,Hepatotoxicity (comment),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (comment),,,,
10040,,,14000668,[],CHEMBL3137739,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,,1,0,,,Hepatotoxicity (time to onset),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (time to onset),,,,
10041,,,14000669,[],CHEMBL3137740,Proposed mechanism(s) of liver damage. [column 'MEC' in source],T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,1980107,,1,0,,,Hepatotoxicity (mechanism),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (mechanism),,,,
10042,,,15097723,[],CHEMBL3385521,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10043,,,15102250,[],CHEMBL3385522,Antibacterial activity against macrolide lincosamide- streptogramin B inducibly-resistant Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10044,,,15102270,[],CHEMBL3385523,Antibacterial activity against macrolide lincosamide- streptogramin B-resistant Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10045,,,15102290,[],CHEMBL3385524,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
10046,,,15102310,[],CHEMBL3385525,Antibacterial activity against macrolide lincosamide- streptogramin B inducibly-resistant Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
10047,,,15102330,[],CHEMBL3385526,Antibacterial activity against efflux-resistant Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
10048,,,15102350,[],CHEMBL3385527,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
10049,,,15102370,[],CHEMBL3385528,Antibacterial activity against macrolide lincosamide- streptogramin B inducibly-resistant Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
10050,,,15102390,[],CHEMBL3385529,Antibacterial activity against efflux-resistant Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
10051,,,15102410,[],CHEMBL3385530,Antibacterial activity against Haemophilus influenzae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351470,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249700,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
10052,,,15105520,[],CHEMBL3387838,Binding affinity to Escherichia coli ribosomes after 2 hrs by fluorescence polarization assay in presence of BODIPY-labeled erythromycin A,B,,,BAO_0000034,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351483,ACS Med Chem Lett,2014.0,"{'bei': '10.09', 'le': '0.19', 'lle': '3.26', 'sei': '4.77'}",CHEMBL1136,TELITHROMYCIN,CHEMBL1136,8.19,0,http://www.openphacts.org/units/Nanomolar,2247333,=,1,1,=,,Kd,nM,,6.4,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Kd,nM,UO_0000065,,6.4
10053,,,15105523,[],CHEMBL3387836,Antimicrobial activity against Staphylococcus aureus ATCC 33591 harboring ermA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351483,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247333,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10054,,,15105525,[],CHEMBL3387832,Antimicrobial activity against Escherichia coli SQ171/2058G harboring ribosome A2058G mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351483,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247333,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
10055,,,15105527,[],CHEMBL3387833,Antimicrobial activity against tolC-negative wild type Escherichia coli DK/pKK3535,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351483,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247333,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
10056,,,15105529,[],CHEMBL3387834,Antimicrobial activity against tolC-negative Escherichia coli DK/2058G harboring ribosome A2058G mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351483,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247333,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
10057,,,15105531,[],CHEMBL3387835,Antimicrobial activity against Staphylococcus aureus UCN14 harboring ribosome A2058T mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3351483,ACS Med Chem Lett,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247333,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
10058,,inactive,15471967,[],CHEMBL3561973,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL1201862,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,1860241,,7,1,,,AC50,nM,,25120.0,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,25.12
10059,,inactive,15483283,[],CHEMBL3562085,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL1201862,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Micromolar,1860241,,7,0,,,Ac50,uM,,25.12,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,25.1188643151
10060,,inactive,15506075,[],CHEMBL3562133,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL1201862,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,1860241,,7,1,,,AC50,nM,,35481.3,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,35.4813
10061,,inactive,15512833,[],CHEMBL3562112,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL1201862,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Micromolar,1860241,,7,0,,,Ac50,uM,,28.18,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,28.1838293126
10062,,inactive,15523362,[],CHEMBL3562088,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL1201862,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Micromolar,1860241,,7,0,,,Ac50,uM,,35.48,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,35.4813389234
10063,,inactive,15593164,[],CHEMBL3562135,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL1201862,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,1860241,,7,1,,,AC50,nM,,28183.8,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,28.1838
10064,,,15711743,[],CHEMBL3615658,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.031
10065,,,15711757,[],CHEMBL3615659,Antimicrobial activity against Streptococcus pneumoniae 07P390 expressing constitutive ermB incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.062
10066,,,15711771,[],CHEMBL3615660,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae PU09 incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
10067,,,15711785,[],CHEMBL3615661,Antimicrobial activity against Streptococcus pyogenes 01-968 expressing inducible ermA incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
10068,,,15711799,[],CHEMBL3615662,Antimicrobial activity against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA incubated for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10069,,,15711813,[],CHEMBL3615663,Antimicrobial activity against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC incubated for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10070,,,15711827,[],CHEMBL3615664,Antimicrobial activity against azithromycin-susceptible and ampicillin-resistant Haemophilus influenzae 11P037 incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
10071,,,15711945,[],CHEMBL3615665,Antimicrobial activity against Streptococcus pyogenes 12-207 expressing mef incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
10072,,,15711947,[],CHEMBL3615666,Antimicrobial activity against erythromycin-susceptible Moraxella catarrhalis 11B366 incubated for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.25
10073,,,15711949,[],CHEMBL3615669,Bactericidal activity against Streptococcus pyogenes 01-968 expressing inducible ermA incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,0.125
10074,,,15711951,[],CHEMBL3615670,Bactericidal activity against Streptococcus pyogenes 12-207 expressing mef incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,1.0
10075,,,15711953,[],CHEMBL3615671,Bactericidal activity against azithromycin-susceptible and ampicillin-resistant Haemophilus influenzae 11P037 incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MBC,ug ml-1,UO_0000274,,4.0
10076,,,15711955,[],CHEMBL3615672,Bactericidal activity against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,>,1,0,>,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
10077,,Not Determined,15711957,[],CHEMBL3615673,Bactericidal activity against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2498934,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
10078,,,15711959,[],CHEMBL3615674,Bactericidal activity against erythromycin-susceptible Moraxella catarrhalis 11B366 incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498934,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MBC,ug ml-1,UO_0000274,,0.25
10079,,,15711961,[],CHEMBL3615792,Ratio of MBC to MIC against Streptococcus pyogenes 01-968 expressing inducible ermA,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2498934,=,1,0,=,,Ratio,,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Ratio,,,,2.0
10080,,,15711963,[],CHEMBL3615793,Ratio of MBC to MIC against Streptococcus pyogenes 12-207 expressing mef,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2498934,=,1,0,=,,Ratio,,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Ratio,,,,2.0
10081,,,15711965,[],CHEMBL3615794,Ratio of MBC to MIC against azithromycin-susceptible and ampicillin-resistant Haemophilus influenzae 11P037,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2498934,=,1,0,=,,Ratio,,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Ratio,,,,4.0
10082,,,15711967,[],CHEMBL3615795,Ratio of MBC to MIC against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2498934,>,1,0,>,,Ratio,,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,8.0
10083,,Not Determined,15711969,[],CHEMBL3615796,Ratio of MBC to MIC against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2498934,,1,0,,,Ratio,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,
10084,,,15711971,[],CHEMBL3615797,Ratio of MBC to MIC against erythromycin-susceptible Moraxella catarrhalis 11B366,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2498934,=,1,0,=,,Ratio,,,1.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Ratio,,,,1.0
10085,,,16470282,[],CHEMBL3768514,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10086,,,16470305,[],CHEMBL3768515,Antibacterial activity against inducibly macrolide-lincosamide-streptogramin B resistant Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10087,,,16470326,[],CHEMBL3768516,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B resistant Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10088,,,16470347,[],CHEMBL3768517,Antibacterial activity against efflux mediated macrolide resistant Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10089,,,16470368,[],CHEMBL3768518,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
10090,,,16470389,[],CHEMBL3768519,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B resistant Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
10091,,,16470410,[],CHEMBL3768520,Antibacterial activity against efflux mediated macrolide resistant Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
10092,,,16470431,[],CHEMBL3768521,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.125
10093,,,16470452,[],CHEMBL3768522,Antibacterial activity against inducibly macrolide-lincosamide-streptogramin B resistant Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.125
10094,,,16470473,[],CHEMBL3768523,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B resistant Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,8.0
10095,,,16471399,[],CHEMBL3766319,Antibacterial activity against efflux mediated macrolide resistant Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
10096,,,16471420,[],CHEMBL3766321,Antibacterial activity against Moraxella catarrhalis by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.125
10097,,,16471441,[],CHEMBL3766320,Antibacterial activity against Haemophilus influenzae by agar microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3763128,Bioorg Med Chem,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756801,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.0
10098,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,17805462,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Single dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Single dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889337,The pharmacokinetics of Telithromycin evaluated after administration of single 800-mg doses to healthy adult subjects.,A,,,BAO_0002119,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,2903246,=,39,1,=,,Cmax,nM,,2339.84,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13729.0,Cmax,mcg/mL,UO_0000065,,1.9
10099,,Median. Range 0.5 To 4.0 Hours,17805463,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Single dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Single dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889337,The pharmacokinetics of Telithromycin evaluated after administration of single 800-mg doses to healthy adult subjects.,A,,,BAO_0003037,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,2903246,=,39,1,=,,Tmax,hr,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13729.0,Tmax,hr,UO_0000032,,1.0
10100,,Terminal,17805464,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Single dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Single dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889337,The pharmacokinetics of Telithromycin evaluated after administration of single 800-mg doses to healthy adult subjects.,A,,,BAO_0002115,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,2903246,=,39,1,=,,T1/2,hr,,7.16,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13729.0,t1/2,hr,UO_0000032,,7.16
10101,,Terminal,17805465,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Single dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Single dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889337,The pharmacokinetics of Telithromycin evaluated after administration of single 800-mg doses to healthy adult subjects.,A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2903246,=,39,0,=,,C(24h),mcg/mL,,0.03,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13729.0,C(24h),mcg/mL,,,0.03
10102,,,17805466,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Single dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Single dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889337,The pharmacokinetics of Telithromycin evaluated after administration of single 800-mg doses to healthy adult subjects.,A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2903246,=,39,1,=,,AUC,ng.hr.mL-1,,8250.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13729.0,AUC(0-24),mcg.hr/mL,,,8.25
10103,,Median. Range 0.5 To 3.0 Hours,17805467,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Multiple dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889338,The pharmacokinetics of Telithromycin evaluated after administration of multiple 800-mg doses to healthy adult subjects.,A,,,BAO_0003037,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,2903246,=,39,1,=,,Tmax,hr,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13730.0,Tmax,hr,UO_0000032,,1.0
10104,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,17805468,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Multiple dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889338,The pharmacokinetics of Telithromycin evaluated after administration of multiple 800-mg doses to healthy adult subjects.,A,,,BAO_0002119,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,2903246,=,39,1,=,,Cmax,nM,,2795.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13730.0,Cmax,mcg/mL,UO_0000065,,2.27
10105,,Terminal,17805469,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Multiple dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889338,The pharmacokinetics of Telithromycin evaluated after administration of multiple 800-mg doses to healthy adult subjects.,A,,,BAO_0002115,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,2903246,=,39,1,=,,T1/2,hr,,9.81,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13730.0,t1/2,hr,UO_0000032,,9.81
10106,,,17805470,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '800.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'adult male and female', 'standard_type': 'GENDER', 'standard_units': None, 'standard_value': None, 'text_value': 'adult male and female', 'type': 'GENDER', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_units': None, 'standard_value': '18.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '18.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Multiple dose', 'standard_type': 'REGIMEN', 'standard_units': None, 'standard_value': None, 'text_value': 'Multiple dose', 'type': 'REGIMEN', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889338,The pharmacokinetics of Telithromycin evaluated after administration of multiple 800-mg doses to healthy adult subjects.,A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2903246,=,39,1,=,,AUC,ng.hr.mL-1,,12500.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13730.0,AUC(0-24),mcg.hr/mL,,,12.5
10107,,,17805471,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Feces', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Feces', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889339,The pharmacokinetics of Telithromycin evaluated after administration of Ketek to subjects.,A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,2903246,=,39,0,=,,Excretion,%,,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13731.0,Excretion,%,UO_0000187,,7.0
10108,,,17805472,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Tablet', 'standard_type': 'DOSAGE_FORM', 'standard_units': None, 'standard_value': None, 'text_value': 'Tablet', 'type': 'DOSAGE_FORM', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'TELITHROMYCIN', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_units': None, 'standard_value': None, 'text_value': 'TELITHROMYCIN', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'healthy', 'standard_type': 'HEALTH_STATUS', 'standard_units': None, 'standard_value': None, 'text_value': 'healthy', 'type': 'HEALTH_STATUS', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'DailyMed', 'standard_type': 'SOURCE', 'standard_units': None, 'standard_value': None, 'text_value': 'DailyMed', 'type': 'SOURCE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Urine', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Urine', 'type': 'TISSUE', 'units': None, 'value': None}]",CHEMBL3889339,The pharmacokinetics of Telithromycin evaluated after administration of Ketek to subjects.,A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL3832548,,,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,2903246,=,39,0,=,,Excretion,%,,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,13732.0,Excretion,%,UO_0000187,,13.0
10109,,,18029368,[],CHEMBL4007156,Bacteriostatic activity against erythromycin-resistant Streptococcus pneumoniae ATCC 49619 after 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,0.031,0.016
10110,,,18029383,[],CHEMBL4007157,Bactericidal activity against erythromycin-resistant Streptococcus pneumoniae ATCC 49619 incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,0.031,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,,0.031
10111,,,18029400,[],CHEMBL4007158,Ratio of MBC to MIC for erythromycin-resistant Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,2.0,1.0
10112,,,18029415,[],CHEMBL4007159,Bacteriostatic activity against penicillin-susceptible Streptococcus pneumoniae PU09 after 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
10113,,,18029432,[],CHEMBL4007160,Bactericidal activity against penicillin-susceptible Streptococcus pneumoniae PU09 incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,1.0,0.5
10114,,,18029449,[],CHEMBL4007161,Ratio of MBC to MIC for penicillin-susceptible Streptococcus pneumoniae PU09,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,4.0,2.0
10115,,,18029463,[],CHEMBL4007162,Bacteriostatic activity against Streptococcus pyogenes 01-968 expressing inducible ermA after 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.062
10116,,,18029480,[],CHEMBL4007163,Bactericidal activity against Streptococcus pyogenes 01-968 expressing inducible ermA incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,0.5,0.125
10117,,,18029497,[],CHEMBL4007164,Ratio of MBC to MIC for Streptococcus pyogenes 01-968 expressing inducible ermA,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Ratio,,,8.0,2.0
10118,,,18029510,[],CHEMBL4007165,Bacteriostatic activity against Streptococcus pyogenes 12-207 expressing mef after 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
10119,,,18029519,[],CHEMBL4007166,Bactericidal activity against Streptococcus pyogenes 12-207 expressing mef incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,1.0
10120,,,18029528,[],CHEMBL4007167,Ratio of MBC to MIC for Streptococcus pyogenes 12-207 expressing mef,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Ratio,,,,2.0
10121,,,18029537,[],CHEMBL4007168,Bacteriostatic activity against azithromycin-susceptible/ampicillin-resistant Haemophilus influenzae 11P307 after 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,4.0,1.0
10122,,,18029548,[],CHEMBL4007169,Bactericidal activity against azithromycin susceptible/ampicillin-resistant Haemophilus influenzae 11P307 incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MBC,ug ml-1,UO_0000274,,4.0
10123,,,18029558,[],CHEMBL4007170,Ratio of MBC to MIC for azithromycin susceptible/ampicillin-resistant Haemophilus influenzae 11P307,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Ratio,,,4.0,1.0
10124,,,18029568,[],CHEMBL4007171,Bacteriostatic activity against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC after 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
10125,,,18029585,[],CHEMBL4007172,Bactericidal activity against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,>,1,0,>,,MBC,ug ml-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,256.0
10126,,,18029605,[],CHEMBL4007174,Bacteriostatic activity against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA after 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,0.25,0.125
10127,,,18029622,[],CHEMBL4007175,Bactericidal activity against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,>,1,0,>,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,2.0,1.0
10128,,,18029639,[],CHEMBL4007176,Ratio of MBC to MIC against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,>,1,0,>,,Ratio,,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,8.0
10129,,,18029651,[],CHEMBL4007177,Bacteriostatic activity against erythromycin-susceptible Moraxella catarrhalis 11B366 after 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.25
10130,,,18029660,[],CHEMBL4007178,Bactericidal activity against erythromycin-susceptible Moraxella catarrhalis 11B366 incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MBC,ug ml-1,UO_0000274,,0.25
10131,,,18029669,[],CHEMBL4007179,Ratio of MBC to MIC against erythromycin-susceptible Moraxella catarrhalis 11B366,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,1.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Ratio,,,,1.0
10132,,,18029678,[],CHEMBL4007180,Bacteriostatic activity against erythromycin-susceptible Moraxella catarrhalis 13L332 after 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.125
10133,,,18029688,[],CHEMBL4007181,Bactericidal activity against erythromycin-susceptible Moraxella catarrhalis 13L332 incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MBC,ug ml-1,UO_0000274,,0.5
10134,,,18029698,[],CHEMBL4007182,Ratio of MBC to MIC against erythromycin-susceptible Moraxella catarrhalis 13L332,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,4.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Ratio,,,,4.0
10135,,,18029706,[],CHEMBL4007183,Bacteriostatic activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 after 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
10136,,,18029711,[],CHEMBL4007184,Bactericidal activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2987381,=,1,0,=,,MBC,ug ml-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MBC,ug ml-1,UO_0000274,,8.0
10137,,,18029716,[],CHEMBL4007185,Ratio of MBC to MIC against azithromycin-susceptible Haemophilus influenzae ATCC 49247,F,,,BAO_0000193,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4004878,Bioorg Med Chem Lett,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2987381,=,1,0,=,,Ratio,,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Ratio,,,,1.0
10138,,,18051772,[],CHEMBL4011663,Inhibition of human BSEP expressed in fall armyworm sf9 cell plasma membrane vesicles assessed as reduction in vesicle-associated [3H]-taurocholate transport preincubated for 10 mins prior to ATP addition measured after 15 mins in presence of [3H]-taurocholate by topcount based membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4011581,Toxicol Sci,2010.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,5.4,0,http://www.openphacts.org/units/Nanomolar,2991641,=,1,1,=,,IC50,nM,,4000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,4.0
10139,,,18051988,[],CHEMBL4011669,Inhibition of recombinant human BSEP expressed in baculovirus infected sf9 cell membrane vesicles assessed as reduction in ATP or AMP-dependent [3H]-taurocholic acid uptake in to vesicles preincubated for 5 mins followed by ATP/AMP addition measured after 5 mins by scintillation counting method,A,,,BAO_0000190,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4011582,Hepatology,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,4.52,0,http://www.openphacts.org/units/Nanomolar,2991921,=,1,1,=,,IC50,nM,,30000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,30.0
10140,,Non-Toxic,18052100,[],CHEMBL4011674,Induction of mitochondrial dysfunction in Sprague-Dawley rat liver mitochondria assessed as inhibition of mitochondrial respiration per mg mitochondrial protein measured for 20 mins by A65N-1 oxygen probe based fluorescence assay,A,,,BAO_0000190,BAO_0000252,mitochondrion format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4011582,Hepatology,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2991921,,1,0,,,IC50,,,,CHEMBL613642,Rattus norvegicus,Liver,10116.0,,,IC50,,,,
10141,,,18052172,[],CHEMBL4011675,Total Cmax in human administered as single dose,A,,,BAO_0002119,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4011582,Hepatology,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,2991921,=,1,1,=,,Cmax,nM,,2770.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,uM,UO_0000065,,2.77
10142,,Toxic,18052246,[],CHEMBL4011678,Hepatotoxicity in human assessed as drug-induced liver injury,T,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4011582,Hepatology,2014.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,2991921,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
10143,,,18129057,[],CHEMBL4028921,Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,5.3,0,http://www.openphacts.org/units/Nanomolar,3006395,=,1,1,=,,IC50,nM,,5000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,5.0
10144,,,18129650,[],CHEMBL4028922,Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3006395,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5748,Homo sapiens,Canalicular multispecific organic anion transporter 1,9606.0,,,IC50,uM,UO_0000065,,133.0
10145,,,18130227,[],CHEMBL4028923,Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3006395,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5918,Homo sapiens,Canalicular multispecific organic anion transporter 2,9606.0,,,IC50,uM,UO_0000065,,133.0
10146,,,18130827,[],CHEMBL4028924,Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,5.15,0,http://www.openphacts.org/units/Nanomolar,3006395,=,1,1,=,,IC50,nM,,7100.0,CHEMBL1743128,Homo sapiens,Multidrug resistance-associated protein 4,9606.0,,,IC50,uM,UO_0000065,,7.1
10147,,standard_value was converted from uM.hr to ng.hr.mL-1 using the parent compound MW | standard_value was converted from uM.hr to ug.hr.mL-1 using the parent compound MW | standard_value was converted from uM.hr to ug.hr.mL-1 using the parent compound MW | standard_value was converted from uM.hr to ug.hr.mL-1 using the parent compound MW | standard_value was converted from uM.hr to ug.hr.mL-1 using the parent compound MW | standard_value was converted from uM.hr to ug.hr.mL-1 using the parent compound MW,18131715,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '12.0'}]",CHEMBL4029233,"AUC in human at 400 mg, po BID for 5 to 10 days after 12 hrs",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3006395,=,1,1,=,,AUC,ng.hr.mL-1,,9386.95,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,uM.hr,,,11.563
10148,,,18131716,[],CHEMBL4029234,"Drug concentration at steady state in human at 400 mg, po BID for 5 to 10 days after 12 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Micromolar,3006395,=,1,0,=,,Css,uM,,0.964,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Css,uM,UO_0000064,,0.964
10149,,,18131717,[],CHEMBL4029235,"Ratio of drug concentration at steady state in human at 400 mg, po BID for 5 to 10 days after 12 hrs to IC50 for human BSEP overexpressed in Sf9 insect cells",A,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3006395,=,1,0,=,,Ratio,,,0.193,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.193
10150,,,18131718,[],CHEMBL4029236,"Ratio of drug concentration at steady state in human at 400 mg, po BID for 5 to 10 days after 12 hrs to IC50 for human MRP4 overexpressed in Sf9 insect cells",A,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3006395,=,1,0,=,,Ratio,,,0.136,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.136
10151,,,18132269,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3007267,=,1,0,=,,DILI_severity_class,,,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,8.0
10152,,Most-Dili-Concern,18132869,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3007267,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
10153,,,18190705,[],CHEMBL4041646,Antibacterial activity against erythromycin susceptible Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10154,,,18190740,[],CHEMBL4041642,Antibacterial activity against inducibly macrolide/lincosamide/streptogramin B-resistant Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10155,,,18190775,[],CHEMBL4041643,Antibacterial activity against constitutively macrolide/lincosamide/streptogramin B-resistant Staphylococcus aureus by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10156,,,18190810,[],CHEMBL4041641,Antibacterial activity against erythromycin susceptible Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
10157,,,18190845,[],CHEMBL4041640,Antibacterial activity against constitutively macrolide/lincosamide/streptogramin B-resistant Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
10158,,,18190880,[],CHEMBL4041645,Antibacterial activity against Mef-mediated macrolide efflux resistant Streptococcus pneumoniae by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
10159,,,18190915,[],CHEMBL4041644,Antibacterial activity against erythromycin susceptible Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
10160,,,18190950,[],CHEMBL4041639,Antibacterial activity against constitutively macrolide/lincosamide/streptogramin B-resistant Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
10161,,,18190985,[],CHEMBL4041647,Antibacterial activity against Mef-mediated macrolide efflux resistant Streptococcus pyogenes by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
10162,,,18191020,[],CHEMBL4041648,Antibacterial activity against Haemophilus influenzae by agar microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017697,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
10163,,,18191031,[],CHEMBL4041650,Antibacterial activity against erythromycin susceptible Staphylococcus aureus infected in mouse assessed as increase in mouse survival administered orally 1 hr post infection,F,,,BAO_0003036,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,ED50,mg.kg-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,5.0
10164,,,18191036,[],CHEMBL4041651,Antibacterial activity against erythromycin susceptible Streptococcus pneumoniae infected in mouse assessed as increase in mouse survival administered orally 1 hr post infection,F,,,BAO_0003036,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,ED50,mg.kg-1,,7.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,7.2
10165,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,18191044,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4041654,"Cmax in Han Wistar rat at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3017697,=,1,1,=,,Cmax,nM,,2278.27,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,1.85
10166,,,18191047,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL4041655,"AUC(0 to infinity) in Han Wistar rat at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,AUC,ng.hr.mL-1,,3950.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,microg.hr/mL,,,3.95
10167,,,18191050,[],CHEMBL4041656,"Terminal half life in Han Wistar rat at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3017697,=,1,1,=,,T1/2,hr,,1.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,beta t1/2,hr,UO_0000032,,1.7
10168,,,18191053,[],CHEMBL4041657,"Clearance in Han Wistar rat at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002759,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,CL,mL.min-1.kg-1,,42.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL,ml/min.kg,,,42.5
10169,,,18191056,[],CHEMBL4041658,"Unbound clearance in Han Wistar rat at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002759,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,CL,mL.min-1.kg-1,,75.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL free,ml/min.kg,,,75.9
10170,,,18191059,[],CHEMBL4041659,"Volume of distribution at steady state in Han Wistar rat at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0003041,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,Vdss,L.kg-1,,5.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Vdss,L/Kg,UO_0000197,,5.6
10171,,,18191062,[],CHEMBL4041661,"Fraction unbound in Han Wistar rat plasma at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,Fu,,,0.56,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Fu,,,,0.56
10172,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,18191070,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4041667,"Cmax in Han Wistar rat at 20 mg/kg, po by LC-MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3017697,=,1,1,=,,Cmax,nM,,418.71,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,0.34
10173,,,18191072,[],CHEMBL4041668,"Tmax in Han Wistar rat at 20 mg/kg, po by LC-MS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3017697,=,1,1,=,,Tmax,hr,,2.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Tmax,hr,UO_0000032,,2.3
10174,,,18191074,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL4041669,"AUC(0 to infinity) in Han Wistar rat at 20 mg/kg, po by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3017697,=,1,1,=,,AUC,ng.hr.mL-1,,2730.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,microg.hr/mL,,,2.73
10175,,,18191076,[],CHEMBL4041670,Oral bioavailability in Han Wistar rat at 20 mg/kg by LC-MS/MS analysis,A,,,BAO_0003042,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3017697,=,1,1,=,,F,%,,33.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,F,%,UO_0000187,,33.0
10176,,,18191083,[],CHEMBL4041673,Protein binding in mouse plasma at 1 ug/ml by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000366,cell-free format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3017697,=,1,1,=,,PPB,%,,59.0,CHEMBL613589,Mus musculus,Plasma,10090.0,,,PPB,%,UO_0000187,,59.0
10177,,,18191088,[],CHEMBL4041674,Protein binding in rat plasma at 1 ug/ml by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000366,cell-free format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3017697,=,1,1,=,,PPB,%,,44.0,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,PPB,%,UO_0000187,,44.0
10178,,,18191093,[],CHEMBL4041675,Protein binding in human plasma at 1 ug/ml by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000366,cell-free format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4041467,Eur J Med Chem,2017.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3017697,=,1,1,=,,PPB,%,,50.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,50.0
10179,,,18305217,[],CHEMBL4125565,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 11X315 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.062
10180,,,18305224,[],CHEMBL4125564,Antibacterial activity against methicillin-resistant Staphylococcus aureus 11B117 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10181,,,18305231,[],CHEMBL4125563,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 11B122 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.062
10182,,,18305244,[],CHEMBL4125566,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 11C176 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.031
10183,,,18305251,[],CHEMBL4125567,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 11G364 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
10184,,,18305258,[],CHEMBL4125568,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 11 J011 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.031
10185,,,18305265,[],CHEMBL4125569,Antibacterial activity against erythromycin-sensitive Streptococcus pyogenes 11L264 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.008
10186,,,18305272,[],CHEMBL4125570,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 11 N369 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.125
10187,,,18305279,[],CHEMBL4125571,Antibacterial activity against azithromycin-sensitive Haemophilus influenzae 11P042 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.0
10188,,,18305286,[],CHEMBL4125572,Antibacterial activity against azithromycin-resistant Haemophilus influenzae 11Q373 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
10189,,,18305299,[],CHEMBL4125573,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
10190,,,18305312,[],CHEMBL4125574,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
10191,,,18305325,[],CHEMBL4125575,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.015
10192,,,18305338,[],CHEMBL4125576,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 13-3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
10193,,,18305351,[],CHEMBL4125577,Antibacterial activity against methicillin-sensitive Streptococcus pyogenes 12-8 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.03
10194,,,18305364,[],CHEMBL4125578,Antibacterial activity against methicillin-resistant Streptococcus pyogenes 12-1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,256.0
10195,,,18305377,[],CHEMBL4125579,Antibacterial activity against clarithromycin-sensitive Moraxella catarrhalis 12-1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.125
10196,,,18305390,[],CHEMBL4125581,Antibacterial activity against clarithromycin-resistant Moraxella catarrhalis 12-2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,256.0
10197,,,18305403,[],CHEMBL4125582,Antibacterial activity against extended spectrum beta-lactamases non-producing Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10198,,,18305416,[],CHEMBL4125580,Antibacterial activity against extended spectrum beta-lactamases producing Klebsiella pneumoniae ATCC 700603 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10199,,,18305429,[],CHEMBL4125583,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4118285,Bioorg Med Chem Lett,2018.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038771,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
10200,,,18834565,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4303101,,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3141063,=,52,1,=,,Inhibition,%,,5.58,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,5.58
10201,,,18836446,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4303122,,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3142716,=,52,0,=,,Hit score,,,0.2926,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.292581477
10202,,,19016487,[],CHEMBL4346868,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC49619 assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,0.031,0.008
10203,,,19016527,[],CHEMBL4346869,Bactericidal activity against erythromycin-susceptible Streptococcus pneumoniae ATCC49619 pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,<=,1,0,<=,,MBC,ug ml-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,0.125,0.008
10204,,,19016567,[],CHEMBL4346871,Selectivity ratio of MBC to MIC for erythromycin-susceptible Streptococcus pneumoniae ATCC49619,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,=,1,0,=,,Selectivity ratio,,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Selectivity ratio,,,4.0,1.0
10205,,,19016607,[],CHEMBL4346873,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae PU 09 expressing mef gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,0.5,0.25
10206,,,19016647,[],CHEMBL4346874,Bactericidal activity against penicillin-susceptible Streptococcus pneumoniae PU 09 expressing mef gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,4.0,0.5
10207,,,19016686,[],CHEMBL4346875,Selectivity ratio of MBC to MIC for penicillin-susceptible Streptococcus pneumoniae PU 09 expressing mef gene,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,=,1,0,=,,Selectivity ratio,,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Selectivity ratio,,,8.0,2.0
10208,,,19016726,[],CHEMBL4346872,Antibacterial activity against Streptococcus pneumoniae 07P390 expressing constitutive ermB gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,0.125,0.016
10209,,,19016755,[],CHEMBL4346876,Bactericidal activity against Streptococcus pneumoniae 07P390 expressing constitutive ermB gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,>=,1,0,>=,,MBC,ug ml-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,1.0,0.125
10210,,,19016779,[],CHEMBL4346877,Selectivity ratio of MBC to MIC for Streptococcus pneumoniae 07P390 expressing constitutive ermB gene,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,>=,1,0,>=,,Selectivity ratio,,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Selectivity ratio,,,,8.0
10211,,,19016819,[],CHEMBL4346870,Antibacterial activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
10212,,,19016859,[],CHEMBL4346878,Bactericidal activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MBC,ug ml-1,UO_0000274,,16.0
10213,,,19016898,[],CHEMBL4346879,Selectivity ratio of MBC to MIC for azithromycin-susceptible Haemophilus influenzae ATCC 49247,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,=,1,0,=,,Selectivity ratio,,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Selectivity ratio,,,,4.0
10214,,,19016938,[],CHEMBL4346880,Antibacterial activity against MLS-resistant Streptococcus pyogenes 01-968 expressing inducible ermB gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,<=,1,1,<=,,MIC,ug.mL-1,,0.002,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,0.031,0.002
10215,,,19016978,[],CHEMBL4346881,Bactericidal activity against MLS-resistant Streptococcus pyogenes 01-968 expressing inducible ermB gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,>=,1,0,>=,,MBC,ug ml-1,,0.016,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,0.125,0.016
10216,,,19017018,[],CHEMBL4346882,Selectivity ratio of MBC to MIC for MLS-resistant Streptococcus pyogenes 01-968 expressing inducible ermB gene,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,>=,1,0,>=,,Selectivity ratio,,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Selectivity ratio,,,8.0,4.0
10217,,,19017058,[],CHEMBL4346867,Antibacterial activity against MLS-resistant Staphylococcus aureus PU 32 expressing inducible ermA gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,0.25,0.125
10218,,,19017098,[],CHEMBL4346883,Bactericidal activity against MLS/methicillin-resistant Staphylococcus aureus PU 32 expressing inducible ermA gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,>=,1,0,>=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
10219,,,19017138,[],CHEMBL4346884,Selectivity ratio of MBC to MIC for MLS/methicillin-resistant Staphylococcus aureus PU 32 expressing inducible ermA gene,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,>=,1,0,>=,,Selectivity ratio,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Selectivity ratio,,,8.0,4.0
10220,,,19017178,[],CHEMBL4346885,Antibacterial activity against MLS-resistant Staphylococcus aureus PU 20 expressing constitutive ermC gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
10221,,,19017221,[],CHEMBL4346888,Antibacterial activity against MLS-resistant Streptococcus pyogenes 12-206 expressing constitutive ermA gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.031
10222,,,19017233,[],CHEMBL4346889,Bactericidal activity against MLS-resistant Streptococcus pyogenes 12-206 expressing constitutive ermA gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,>,1,0,>,,MBC,ug ml-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,0.25
10223,,,19017245,[],CHEMBL4346890,Selectivity ratio of MBC to MIC for MLS-resistant Streptococcus pyogenes 12-206 expressing constitutive ermA gene,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,>,1,0,>,,Selectivity ratio,,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Selectivity ratio,,,,8.0
10224,,,19017258,[],CHEMBL4346891,Antibacterial activity against Streptococcus pyogenes 12-207 expressing mef gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
10225,,,19017271,[],CHEMBL4346892,Bactericidal activity against Streptococcus pyogenes 12-207 expressing mef gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,1.0
10226,,,19017284,[],CHEMBL4346893,Selectivity ratio of MBC to MIC for Streptococcus pyogenes 12-207 expressing mef gene,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,=,1,0,=,,Selectivity ratio,,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Selectivity ratio,,,,4.0
10227,,,19017297,[],CHEMBL4346894,Antibacterial activity against erythromycin-susceptible Moraxella catarrhalis 13L332 assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.25
10228,,,19017310,[],CHEMBL4346895,Bactericidal activity against erythromycin-susceptible Moraxella catarrhalis 13L332 pretreated followed by subculture in absence of compound measured after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173324,>,1,0,>,,MBC,ug ml-1,,2.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MBC,ug ml-1,UO_0000274,,2.0
10229,,,19017323,[],CHEMBL4346896,Selectivity ratio of MBC to MIC for erythromycin-susceptible Moraxella catarrhalis 13L332,F,,,BAO_0002136,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,>,1,0,>,,Selectivity ratio,,,8.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Selectivity ratio,,,,8.0
10230,,,19017327,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL4346897,"AUCinfinity in Sprague-Dawley rat at 20 mg/kg, po after 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,=,1,1,=,,AUC,ng.hr.mL-1,,927.0,CHEMBL612558,,ADMET,,,,AUC,hr.ng/ml,,,927.0
10231,,,19017331,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'TIME_LOWER', 'standard_units': 'hr', 'standard_value': '0.25', 'text_value': None, 'type': 'TIME_LOWER', 'units': 'hr', 'value': '0.25'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'TIME_UPPER', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_UPPER', 'units': 'hr', 'value': '24.0'}]",CHEMBL4346898,"AUC (0 to t) in Sprague-Dawley rat at 20 mg/kg, po after 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,=,1,1,=,,AUC,ng.hr.mL-1,,897.0,CHEMBL612558,,ADMET,,,,AUCt,hr.ng/ml,,,897.0
10232,,,19017335,[],CHEMBL4346899,"Systemic plasma clearance in Sprague-Dawley rat at 20 mg/kg, po after 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002759,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3173324,=,1,1,=,,CL,mL.min-1.kg-1,,362.63,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,CL,ml/hr.kg,,,21758.0
10233,,,19017339,[],CHEMBL4346900,"Half life in Sprague-Dawley rat at 20 mg/kg, po after 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3173324,=,1,1,=,,T1/2,hr,,1.22,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,1.22
10234,,,19017343,[],CHEMBL4346901,"MRT in Sprague-Dawley rat at 20 mg/kg, po after 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3173324,=,1,1,=,,MRT,hr,,3.27,CHEMBL612558,,ADMET,,,,MRT,hr,UO_0000032,,3.27
10235,,,19017347,[],CHEMBL4346902,"Tmax in Sprague-Dawley rat at 20 mg/kg, po after 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3173324,=,1,1,=,,Tmax,hr,,2.0,CHEMBL612558,,ADMET,,,,Tmax,hr,UO_0000032,,2.0
10236,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19017351,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4346903,"Cmax in Sprague-Dawley rat at 20 mg/kg, po after 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3173324,=,1,1,=,,Cmax,nM,,251.23,CHEMBL612558,,ADMET,,,,Cmax,ng/ml,UO_0000065,,204.0
10237,,,19017356,[],CHEMBL4346904,Inhibition of CYP3A4 in human liver microsomes assessed as reduction in metabolite formation using midazolam as substrate incubated for 10 mins in presence of NADPH by HPLC based mass spectrometric method,A,,,BAO_0000190,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346654,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,4.93,1,http://www.openphacts.org/units/Nanomolar,3173324,=,1,1,=,,IC50,nM,,11800.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,uM,UO_0000065,,11.8
10238,,,19024960,[],CHEMBL4348321,Antimicrobial activity against mef-encoded erythromycin resistant Streptococcus pneumoniae PU09 incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,1.0,0.25
10239,,,19024993,[],CHEMBL4348320,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,0.032,0.03
10240,,,19025004,[],CHEMBL4348322,Antimicrobial activity against constitutively erythromycin resistant Streptococcus pneumoniae PU27 expressing c-erm incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,<=,1,1,<=,,MIC,ug.mL-1,,0.032,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.032
10241,,,19025016,[],CHEMBL4348323,Antimicrobial activity against constitutively erythromycin resistant Streptococcus pyogenes A2 expressing c-erm incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,32.0
10242,,,19025028,[],CHEMBL4348324,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes A3 incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,<=,1,1,<=,,MIC,ug.mL-1,,0.032,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.032
10243,,,19025040,[],CHEMBL4348325,Antimicrobial activity against erythromycin-susceptible Staphylococcus aureus ATCC 29213 incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10244,,,19025052,[],CHEMBL4348326,Antimicrobial activity against inducibly erythromycin-resistant Staphylococcus aureus PU32 expressing i-ermA incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10245,,,19025064,[],CHEMBL4348327,Antimicrobial activity against constitutively erythromycin resistant Staphylococcus aureus PU20 expressing c-ermC incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
10246,,,19025076,[],CHEMBL4348328,Antimicrobial activity against inducibly erythromycin resistant Staphylococcus aureus PU64 expressing i-ermA incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10247,,,19025088,[],CHEMBL4348329,Antimicrobial activity against Staphylococcus epidermidis E1 incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
10248,,,19025099,[],CHEMBL4348330,Bactericidal activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 assessed as reduction in colony formation incubated in CAMHB medium for 20 to 24 hrs followed by 24 hrs subculturing in the medium without test compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,0,=,,MBC,ug ml-1,,0.031,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,0.125,0.031
10249,,,19025122,[],CHEMBL4348331,Ratio of MBC to MIC for erythromycin-susceptible Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,0,=,,Ratio,,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,4.0,1.0
10250,,,19025145,[],CHEMBL4348332,Bactericidal activity against mef-encoded erythromycin resistant Streptococcus pneumoniae PU09 assessed as reduction in colony formation incubated in CAMHB medium for 20 to 24 hrs followed by 24 hrs subculturing in the medium without test compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,4.0,1.0
10251,,,19025168,[],CHEMBL4348333,Ratio of MBC to MIC for mef-encoded erythromycin resistant Streptococcus pneumoniae PU09,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,0,=,,Ratio,,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,8.0,4.0
10252,,,19025191,[],CHEMBL4348334,Antimicrobial activity against inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,0.062,0.031
10253,,,19025213,[],CHEMBL4348335,Bactericidal activity against inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA assessed as reduction in colony formation incubated in CAMHB medium for 20 to 24 hrs followed by 24 hrs subculturing in the medium without test compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,0,=,,MBC,ug ml-1,,0.13,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,0.5,0.13
10254,,,19025235,[],CHEMBL4348336,Ratio of MBC to MIC for inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,0,=,,Ratio,,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Ratio,,,8.0,4.0
10255,,,19025257,[],CHEMBL4348337,Antimicrobial activity against constitutively erythromycin resistant and methicillin resistant Staphylococcus aureus PU20 expressing c-ermC incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
10256,,,19025279,[],CHEMBL4348338,Bactericidal activity against constitutively erythromycin resistant and methicillin-resistant Staphylococcus aureus PU20 expressing c-ermC assessed as reduction in colony formation incubated in CAMHB medium for 20 hrs followed by 24 hrs subculturing in the medium without test compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,>,1,0,>,,MBC,ug ml-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,256.0
10257,,,19025298,[],CHEMBL4348340,Antimicrobial activity against inducibly erythromycin-resistant and methicillin resistant Staphylococcus aureus PU32 expressing i-ermA incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10258,,,19025320,[],CHEMBL4348341,Bactericidal activity against inducibly erythromycin-resistant and methicillin resistant Staphylococcus aureus PU32 expressing i-ermA assessed as reduction in colony formation incubated in CAMHB medium for 20 hrs followed by 24 hrs subculturing in the medium without test compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,>=,1,0,>=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,2.0,1.0
10259,,,19025342,[],CHEMBL4348342,Ratio of MBC to MIC for inducibly erythromycin-resistant and methicillin resistant Staphylococcus aureus PU32 expressing i-ermA,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,>=,1,0,>=,,Ratio,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,8.0,4.0
10260,,,19025355,[],CHEMBL4348343,Antimicrobial activity against erythromycin-susceptible Moraxella catarrhalis 13L332 incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.125
10261,,,19025362,[],CHEMBL4348344,Bactericidal activity against erythromycin-susceptible Moraxella catarrhalis 13L332 assessed as reduction in colony formation incubated in CAMHB medium for 20 hrs followed by 24 hrs subculturing in the medium without test compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174104,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MBC,ug ml-1,UO_0000274,,0.5
10262,,,19025369,[],CHEMBL4348345,Ratio of MBC to MIC for erythromycin-susceptible Moraxella catarrhalis 13L332,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,0,=,,Ratio,,,4.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Ratio,,,,4.0
10263,,,19025424,[],CHEMBL4348349,Bactericidal activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 assessed as log reduction in bacterial CFU at 1 to 16XMIC incubated for 1 to 24 hrs by broth dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,0,=,,Activity,log10CFU,,3.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,log10CFU,,,3.0
10264,,Active,19025427,[],CHEMBL4348352,Bactericidal activity against mef-encoded erythromycin resistant Streptococcus pneumoniae PU09 at 1 to 16xMIC incubated for 1 to 24 hrs by broth dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
10265,,Active,19025432,[],CHEMBL4348355,Bactericidal activity against inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA at 1XMIC incubated for 12 hrs by broth dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,,1,0,,,Activity,,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,,,,
10266,,Not Active,19025433,[],CHEMBL4348356,Bactericidal activity against inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA at 1XMIC incubated for 24 hrs by broth dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,,1,0,,,Activity,,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,,,,
10267,,,19025434,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL4348357,"AUCinfinity in Sprague-Dawley rat at 20 mg/kg, po administered as single dose measured for 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,1,=,,AUC,ng.hr.mL-1,,927.0,CHEMBL612558,,ADMET,,,,AUC,hr.ng/ml,,,927.0
10268,,,19025436,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'TIME_LOWER', 'standard_units': 'hr', 'standard_value': '0.25', 'text_value': None, 'type': 'TIME_LOWER', 'units': 'hr', 'value': '0.25'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'TIME_UPPER', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_UPPER', 'units': 'hr', 'value': '24.0'}]",CHEMBL4348358,"AUC (0 to t) in Sprague-Dawley rat at 20 mg/kg, po administered as single dose measured for 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,1,=,,AUC,ng.hr.mL-1,,897.0,CHEMBL612558,,ADMET,,,,AUCt,hr.ng/ml,,,897.0
10269,,,19025438,[],CHEMBL4348359,"Clearance in Sprague-Dawley rat at 20 mg/kg, po administered as single dose measured for 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002759,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3174104,=,1,1,=,,CL,mL.min-1.kg-1,,362.64,CHEMBL612558,,ADMET,,,,CL,ml/hr/kg,,,21758.0
10270,,,19025440,[],CHEMBL4348360,"Half life in Sprague-Dawley rat at 20 mg/kg, po administered as single dose measured for 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3174104,=,1,1,=,,T1/2,hr,,1.22,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,1.22
10271,,,19025442,[],CHEMBL4348361,"MRT in Sprague-Dawley rat at 20 mg/kg, po administered as single dose measured for 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3174104,=,1,1,=,,MRT,hr,,3.27,CHEMBL612558,,ADMET,,,,MRT,hr,UO_0000032,,3.27
10272,,,19025444,[],CHEMBL4348362,"Tmax in Sprague-Dawley rat at 20 mg/kg, po administered as single dose measured for 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3174104,=,1,1,=,,Tmax,hr,,2.0,CHEMBL612558,,ADMET,,,,Tmax,hr,UO_0000032,,2.0
10273,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19025446,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4348363,"Cmax in Sprague-Dawley rat at 20 mg/kg, po administered as single dose measured for 0.25 to 24 hrs by LC-MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3174104,=,1,1,=,,Cmax,nM,,251.23,CHEMBL612558,,ADMET,,,,Cmax,ng/ml,UO_0000065,,204.0
10274,,,19025448,[],CHEMBL4348364,Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate incubated for 10 mins after substrate addition by HPLC analysis,A,,,BAO_0000190,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4346684,Eur J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,4.93,0,http://www.openphacts.org/units/Nanomolar,3174104,=,1,1,=,,IC50,nM,,11800.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,uM,UO_0000065,,11.8
10275,,,19314401,[],CHEMBL4416747,Antibacterial activity against Escherichia coli K-12 assessed as reduction in bacterial growth incubated for 16 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4414638,J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3225251,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.6
10276,,Non-Toxic,19314457,[],CHEMBL4416768,Cytotoxicity in human HS5 cells assessed as reduction in cell viability at 0.5 to 50 uM incubated up to 72 hrs relative to chloramphenicol,A,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4414638,J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3225251,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
10277,,Toxic,19314513,[],CHEMBL4416770,Cytotoxicity in human HEK293 cells assessed as reduction in cell viability at 0.5 uM incubated up to 72 hrs relative to chloramphenicol,A,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4414638,J Med Chem,2019.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3225251,,1,0,,,Activity,,,,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,Activity,,,,
10278,,,19963416,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4495564,,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3349834,=,52,1,=,,Inhibition,%,,2.973,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,2.973318752
10279,,,20147018,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4495565,,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3367706,=,52,1,=,,Inhibition,%,,-0.19,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.19
10280,,,20599346,[],CHEMBL4603061,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4602606,J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3465046,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.06
10281,,,20599347,[],CHEMBL4603062,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4602606,J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3465046,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.25
10282,,,20599349,[],CHEMBL4603064,Inhibition of human nAChR expressed in human TE671 cells assessed as reduction in nicotine-induced current response by whole-cell patch-clamp method,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4602606,J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,5.46,0,http://www.openphacts.org/units/Nanomolar,3465046,=,1,1,=,,IC50,nM,,3500.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,3.5
10283,,,20599350,[],CHEMBL4603065,Inhibition of human alpha3beta4 nAChR assessed as increase in acetylcholine-induced normalized current at 2 uM (Rvb = 78.5 +/- 10 uM),A,,,BAO_0000188,BAO_0000223,protein complex format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4602606,J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3465046,=,1,1,=,,EC50,nM,,132000.0,CHEMBL1907594,Homo sapiens,Neuronal acetylcholine receptor; alpha3/beta4,9606.0,,,EC50,uM,UO_0000065,,132.0
10284,,,22079196,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4495565,,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3367706,=,52,1,=,,Inhibition,%,,-0.19,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.19
10285,,,22476343,[],CHEMBL4686398,Antibacterial activity against Erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 assessed as reduction in microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
10286,,,22476373,[],CHEMBL4686399,Bactericidal activity against Erythromycin-susceptible Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,<=,1,0,<=,,MBC,ug ml-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,,0.008
10287,,,22476403,[],CHEMBL4686400,Ratio of MBC to MIC against Erythromycin-susceptible Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3522807,=,1,0,=,,Ratio,,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,1.0
10288,,,22476434,[],CHEMBL4686401,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae PU09 harboring mef gene assessed as reduction in microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
10289,,,22476465,[],CHEMBL4686402,Bactericidal activity against penicillin-susceptible Streptococcus pneumoniae PU09 harboring mef gene,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,,0.5
10290,,,22476495,[],CHEMBL4686403,Ratio of MBC to MIC against penicillin-susceptible Streptococcus pneumoniae PU09,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3522807,=,1,0,=,,Ratio,,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,2.0
10291,,,22476526,[],CHEMBL4686404,Antibacterial activity against MLSB-resistant Streptococcus pneumoniae 07P390 harboring ermB gene assessed as reduction in microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
10292,,,22476557,[],CHEMBL4686405,Bactericidal activity against MLSB-resistant Streptococcus pneumoniae 07P390 harboring ermB gene assessed as reduction in microbial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,>,1,0,>,,MBC,ug ml-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,,0.125
10293,,,22476580,[],CHEMBL4686406,Ratio of MBC to MIC against MLSB-resistant Streptococcus pneumoniae 07P390 harboring ermB,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3522807,>,1,0,>,,Ratio,,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,8.0
10294,,,22476610,[],CHEMBL4686407,Antibacterial activity against MLSB/methicillin/ciprofloxacin-resistant Staphylococcus aureus PU32 harboring ermA gene assessed as reduction in microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10295,,,22476694,[],CHEMBL4686410,Antibacterial activity against MLSB/methicillin-resistant Staphylococcus aureus 15B196 assessed as reduction in microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10296,,,22476756,[],CHEMBL4686413,Antibacterial activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 assessed as reduction in microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
10297,,,22476885,[],CHEMBL4686432,Antibacterial activity against MLSB-resistant Streptococcus pyogenes 12-206 harboring ermA gene assessed as reduction in microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522807,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
10298,,,22476927,[],CHEMBL4686435,Antibacterial activity against MLSB/methicillin/ciprofloxacin-resistant Staphylococcus aureus PU32 harboring ermA gene assessed as reduction in microbial growth relative to ciprofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3522807,=,1,0,=,,FC,,,0.0032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,0.0032
10299,,,22476934,[],CHEMBL4686436,Antibacterial activity against MLSB/methicillin-resistant Staphylococcus aureus 15B196 assessed as reduction in microbial growth relative to ciprofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3522807,>,1,0,>,,FC,,,52.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,52.0
10300,,,22476941,[],CHEMBL4686437,Antibacterial activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 assessed as reduction in microbial growth relative to ciprofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4680236,Eur J Med Chem,2020.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3522807,=,1,0,=,,FC,,,407.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,FC,,,,407.0
10301,,,23131940,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4808148,,2021.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3595987,=,59,1,=,,Inhibition,%,,-3.57,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-3.57
10302,,,23138548,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL4808148,,2021.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3595987,=,59,1,=,,Inhibition,%,,1.1,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,1.1
10303,,,24759292,[],CHEMBL5123350,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
10304,,,24759318,[],CHEMBL5123351,Antibacterial activity against Streptococcus pneumoniae 07P390 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
10305,,,24759344,[],CHEMBL5123352,Antibacterial activity against Streptococcus pneumoniae PU09 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
10306,,,24759370,[],CHEMBL5123353,Antibacterial activity against Streptococcus pyogenes 12-206 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.12
10307,,,24759396,[],CHEMBL5123354,Antibacterial activity against Staphylococcus aureus 15B196 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10308,,,24759422,[],CHEMBL5123355,Antibacterial activity against Staphylococcus aureus PU32 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10309,,,24759448,[],CHEMBL5123356,Antibacterial activity against Haemophilus influenzae ATCC 49247 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
10310,,,24759474,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL5123357,Stability in rat liver microsomes assessed as unchanged drug level at 1 uM by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3862917,=,1,1,=,,Stability,%,,93.2,CHEMBL612558,,ADMET,,,,Stability,%,UO_0000187,,93.2
10311,,,24759478,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL5123358,Stability in rat liver microsomes assessed as unchanged drug level at 1 uM after 60 mins by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Percent,3862917,=,1,1,=,,Stability,%,,26.3,CHEMBL612558,,ADMET,,,,Stability,%,UO_0000187,,26.3
10312,,,24759482,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '1.0'}]",CHEMBL5123359,Half life in human liver microsomes at 1 uM by LC-MS/MS analysis,A,,,BAO_0002115,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://qudt.org/vocab/unit#Hour,3862917,=,1,1,=,,T1/2,hr,,0.54,CHEMBL612558,,ADMET,,,,t1/2,min,UO_0000032,,32.4
10313,,,24759486,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '1.0'}]",CHEMBL5123360,Intrinsic clearance in human liver microsomes at 1 uM by LC-MS/MS analysis,A,,,BAO_0002759,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,,3862917,=,1,1,=,,CL,mL.min-1.kg-1,,38.4,CHEMBL612558,,ADMET,,,,CLH,ml/min.kg,,,38.4
10314,,,24759490,[],CHEMBL5123361,Antibacterial activity against erythromycin-susceptible Mycoplasma pneumoniae ATCC 29342 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.008
10315,,,24759493,[],CHEMBL5123362,Antibacterial activity against erythromycin-resistant Mycoplasma pneumoniae A2058G by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,256.0
10316,,,24759496,[],CHEMBL5123363,Antibacterial activity against erythromycin-resistant Mycoplasma pneumoniae A2059G by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,256.0
10317,,,24759499,[],CHEMBL5123364,Antibacterial activity against erythromycin-resistant Mycoplasma pneumoniae A2058T by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862917,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,256.0
10318,,,25026418,[],CHEMBL5240638,Antibacterial activity against ESBL positive Klebsiella pneumoniae ATCC 700603 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10319,,,25026435,[],CHEMBL5240639,Antibacterial activity against ESBL negative Klebsiella pneumoniae 7 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10320,,,25026452,[],CHEMBL5240640,Antibacterial activity against ESBL negative Klebsiella pneumoniae 16-2 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10321,,,25026469,[],CHEMBL5240641,Antibacterial activity against erythromycin-sensitive Streptococcus pyogenes ATCC 19615 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
10322,,,25026486,[],CHEMBL5240642,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 12-1 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,64.0
10323,,,25026503,[],CHEMBL5240643,Antibacterial activity against vancomycin-sensitive Enterococcus faecalis ATCC29213 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.12
10324,,,25026520,[],CHEMBL5240644,Antibacterial activity against vancomycin-sensitive Enterococcus faecalis 16-6 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
10325,,,25026537,[],CHEMBL5240645,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
10326,,,25026554,[],CHEMBL5240646,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
10327,,,25026571,[],CHEMBL5240647,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae ATCC 49619 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
10328,,,25026588,[],CHEMBL5240648,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 12-3 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
10329,,,25026605,[],CHEMBL5240649,Antibacterial activity against ESBL-negative Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10330,,,25026622,[],CHEMBL5240650,Antibacterial activity against Escherichia coli 16-7 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10331,,,25026639,[],CHEMBL5240651,Antibacterial activity against ESBL-positive Escherichia coli ATCC 35218 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10332,,,25026656,[],CHEMBL5240652,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
10333,,,25026673,[],CHEMBL5240653,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 16-4 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
10334,,,25026690,[],CHEMBL5240654,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10335,,,25026707,[],CHEMBL5240655,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 15 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10336,,,25026724,[],CHEMBL5240656,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 16-1 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10337,,,25026741,[],CHEMBL5240657,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
10338,,,25026758,[],CHEMBL5240658,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
10339,,,25026775,[],CHEMBL5240659,Antibacterial activity against Pseudomonas aeruginosa 16-11 assessed as inhibition of bacterial growth by CLSI based micro broth double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5236651,Bioorg Med Chem Lett,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3917541,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
10340,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25115261,[],CHEMBL5291779,Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10341,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25117717,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
10342,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25125010,[],CHEMBL5291882,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
10343,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138909,[],CHEMBL5291792,Binding affinity towards human ESR1 in an in vitro cell free assay (CRO assay) measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
10344,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25142599,[],CHEMBL5291723,Compound was evaluated for inhibition of human ACHE in an vitro cell free assay measured by absorbance method,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,AC50,uM,UO_0000065,,30.0
10345,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25146051,[],CHEMBL5291881,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
10346,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25151378,[],CHEMBL5291883,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
10347,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25156480,[],CHEMBL5291736,Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10348,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25158226,[],CHEMBL5291855,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10349,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25160742,[],CHEMBL5291830,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
10350,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25165075,[],CHEMBL5291815,Binding affinity towards human HTR1A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10351,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25168264,[],CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL279,Homo sapiens,Vascular endothelial growth factor receptor 2,9606.0,,,AC50,uM,UO_0000065,,30.0
10352,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25191768,[],CHEMBL5291856,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
10353,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25194573,[],CHEMBL5291782,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10354,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25195787,[],CHEMBL5291766,Binding affinity towards human CHRM2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
10355,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25196757,[],CHEMBL5291794,Compound was evaluated for inhibition of human F2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL204,Homo sapiens,Thrombin,9606.0,,,AC50,uM,UO_0000065,,30.0
10356,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25197907,[],CHEMBL5291888,Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10357,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25198758,[],CHEMBL5291728,Binding affinity towards human ADORA3 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10358,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25199583,[],CHEMBL5291812,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10359,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25201516,[],CHEMBL5291820,Agonist activity at human HTR2B in an in vitro cell-based assay (CRO assay) measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10360,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25202472,[],CHEMBL5291725,Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10361,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25202778,[],CHEMBL5291799,Binding affinity towards human GABRA1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000223,protein complex format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,30.0
10362,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25203409,[],CHEMBL5291749,Binding affinity towards human AR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1871,Homo sapiens,Androgen Receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10363,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25204342,[],CHEMBL5291863,Binding affinity towards human PGR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10364,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25205275,[],CHEMBL5291869,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,4.69,0,http://www.openphacts.org/units/Nanomolar,3941135,=,1,1,=,,AC50,nM,,20620.1,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,20.6201
10365,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25206207,[],CHEMBL5291871,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by fluorescence method,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
10366,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207138,[],CHEMBL5291857,Compound was evaluated for inhibition of human PDE4A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL254,Homo sapiens,Phosphodiesterase 4A,9606.0,,,AC50,uM,UO_0000065,,30.0
10367,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207918,[],CHEMBL5291800,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
10368,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25208574,[],CHEMBL5291730,Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10369,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25209422,[],CHEMBL5291759,Agonist activity at human CHRM1 in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
10370,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210256,[],CHEMBL5291761,Antagonist activity human CHRM1 in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
10371,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25211145,[],CHEMBL5291887,Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10372,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218891,[],CHEMBL5291731,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1136,TELITHROMYCIN,CHEMBL1136,,0,http://www.openphacts.org/units/Nanomolar,3941135,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
10373,,,2127835,[],CHEMBL935853,Antibacterial activity against wild type Staphylococcus aureus RN4220,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10374,,,2127857,[],CHEMBL935854,Antibacterial activity against Staphylococcus aureus RN4220 with rplC D159Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10375,,,2127862,[],CHEMBL935855,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G155R mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10376,,,2127867,[],CHEMBL935856,Antibacterial activity against Staphylococcus aureus RN4220 with rplC S158L mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10377,,,2127872,[],CHEMBL935857,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10378,,,2127877,[],CHEMBL935858,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D and D159Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
10379,,,2127882,[],CHEMBL935859,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D and G155R mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
10380,,,2127887,[],CHEMBL935860,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y and G144R mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10381,,,2127892,[],CHEMBL935861,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y and G155R mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10382,,,2127897,[],CHEMBL935862,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y, G155R and H134N mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10383,,,2127902,[],CHEMBL935863,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y, G155R and A150T mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10384,,,2127906,[],CHEMBL935864,"Antibacterial activity against Staphylococcus aureus 2A1-1 with rplC G152D, D159Y and unmapped mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10385,,,2127910,[],CHEMBL935865,"Antibacterial activity against Staphylococcus aureus 2A1-7 with rplC G152D, D159Y and unmapped mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10386,,,2127914,[],CHEMBL935866,"Antibacterial activity against Staphylococcus aureus 2A1-8 with rplC G152D, D159Y and unmapped mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10387,,,2127918,[],CHEMBL935867,Antibacterial activity against Staphylococcus aureus 2A1-1 fast1 with rplC D159Y and unmapped mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10388,,,2127922,[],CHEMBL935868,Antibacterial activity against Staphylococcus aureus 2A1-1 fast2 with rplC D159Y and unmapped mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10389,,,2127926,[],CHEMBL935869,Antibacterial activity against Staphylococcus aureus 2A1-7 fast1 with rplC D159Y and unmapped mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10390,,,2127930,[],CHEMBL935870,Antibacterial activity against Staphylococcus aureus 2A1-7 fast2 with rplC D159Y and unmapped mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703777,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10391,,,2228579,[],CHEMBL1003079,Binding affinity to Escherichia coli MRE600 ribosome assessed as protection against N1-cyclohexyl-N3-(2-morpholino)ethylcarbodiimide p-toluenesulfonate-induced modifications at nucleotide U2506 in peptidyl transferase center of 23S rRNA at 5 uM by chemical footprinting relative to control,B,,,BAO_0000375,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1156624,J Med Chem,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,797336,=,1,0,=,,Activity,,,0.1,CHEMBL612545,,Unchecked,,,,Activity,,,,0.1
10392,,,2228593,[],CHEMBL1003080,Binding affinity to Escherichia coli MRE600 ribosome assessed as protection against N1-cyclohexyl-N3-(2-morpholino)ethylcarbodiimide p-toluenesulfonate-induced modifications at nucleotide U2506 in peptidyl transferase center of 23S rRNA at 50 uM by chemical footprinting relative to control,B,,,BAO_0000375,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1156624,J Med Chem,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,797336,=,1,0,=,,Activity,,,0.05,CHEMBL612545,,Unchecked,,,,Activity,,,,0.05
10393,,,2228614,[],CHEMBL1003081,Binding affinity to Escherichia coli MRE600 ribosome assessed as protection against N1-cyclohexyl-N3-(2-morpholino)ethylcarbodiimide p-toluenesulfonate-induced modifications at nucleotide U2585 in peptidyl transferase center of 23S rRNA at 5 uM by chemical footprinting relative to control,B,,,BAO_0000375,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1156624,J Med Chem,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,797336,=,1,0,=,,Activity,,,0.59,CHEMBL612545,,Unchecked,,,,Activity,,,,0.59
10394,,,2228635,[],CHEMBL1003082,Binding affinity to Escherichia coli MRE600 ribosome assessed as protection against N1-cyclohexyl-N3-(2-morpholino)ethylcarbodiimide p-toluenesulfonate-induced modifications at nucleotide U2585 in peptidyl transferase center of 23S rRNA at 50 uM by chemical footprinting relative to control,B,,,BAO_0000375,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1156624,J Med Chem,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,797336,=,1,0,=,,Activity,,,0.58,CHEMBL612545,,Unchecked,,,,Activity,,,,0.58
10395,,,3453716,[],CHEMBL1246593,"Antimicrobial activity against Staphylococcus aureus 25 transformant carrying plasmid pKKS25 and expressing erm(T), dfrKtet(L), tet(K), tet(M), mecA and blaZ genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1240375,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952266,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10396,,,3453733,[],CHEMBL1246592,"Antimicrobial activity against Staphylococcus aureus RN4220 transformant carrying plasmid pKKS25 and expressing erm(T), dfrK and tet(L) genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1240375,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952266,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
10397,,,3453750,[],CHEMBL1246591,Antimicrobial activity against Staphylococcus aureus RN4220 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1240375,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952266,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
10398,,,3475256,[],CHEMBL1264172,Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid LI50 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255328,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961739,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10399,,,3475257,[],CHEMBL1264173,Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid MS2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255328,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961739,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10400,,,3475258,[],CHEMBL1264174,Antimicrobial activity against methicillin-resistant Staphylococcus aureus CM05 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255328,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961739,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
10401,,,3492710,[],CHEMBL1262580,Antimicrobial activity against wild type Staphylococcus aureus RN4220 measured after 2 days of subculturing by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10402,,,3492712,[],CHEMBL1262582,Antimicrobial activity against mutS-expressing Staphylococcus aureus RN4220 measured after 1 day of subculturing by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10403,,,3492714,[],CHEMBL1262584,Antimicrobial activity against tiamulin resistant Staphylococcus aureus 8325-4 after 1 day of subculturing by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10404,,,3492717,[],CHEMBL1262586,Antimicrobial activity wild type Escherichia coli SQ110 by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10405,,,3492718,[],CHEMBL1262578,Antimicrobial activity against tiamulin resistant Escherichia coli SQ110 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
10406,,,3492734,[],CHEMBL1262587,Antimicrobial activity against Escherichia coli KM55-68 harboring G2576U mutation in 23S rRNA by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10407,,,3492735,[],CHEMBL1262588,Antimicrobial activity against Escherichia coli KM69-73 harboring G2576U mutation in 23S rRNA by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10408,,,3492736,[],CHEMBL1262589,Antimicrobial activity against Escherichia coli KM74 harboring U2500A mutation in 23S rRNA by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10409,,,3492737,[],CHEMBL1262590,Antimicrobial activity against Escherichia coli KM75-84 harboring Gly153Arg mutation in rplC gene by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
10410,,,3492738,[],CHEMBL1262591,Antimicrobial activity against Escherichia coli KM85-86 harboring Lys157Gln mutation in rplC gene by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
10411,,,3492739,[],CHEMBL1262592,Antimicrobial activity against Escherichia coli KM87-88 harboring Arg141Ser mutation in rplC gene by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10412,,,3492740,[],CHEMBL1262593,Antimicrobial activity against Escherichia coli KM89-94 harboring G2576U mutation in 23S rRNA by agar dilution method in presence of 16 ug/ml polymyxin B nonapeptide,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10413,,,3492741,[],CHEMBL1262594,Antimicrobial activity against Staphylococcus aureus KM164-165 harboring Gly155Arg mutation in rplC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
10414,,,3492742,[],CHEMBL1262595,Antimicrobial activity against Staphylococcus aureus KM166-167 harboring Ser158Leu mutation in rplC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
10415,,,3492743,[],CHEMBL1262596,Antimicrobial activity against Staphylococcus aureus RN4220 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10416,,,3492744,[],CHEMBL1262597,Antimicrobial activity against Staphylococcus aureus KM168 harboring Arg149Ser mutation in rplC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
10417,,,3492745,[],CHEMBL1262598,Antimicrobial activity against Staphylococcus aureus KM187+198 harboring G2576U mutation in 23S rRNA by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
10418,,,3492746,[],CHEMBL1262599,Antimicrobial activity against Staphylococcus aureus NRS119 clinical isolate harboring G2576U mutation in 23S rRNA by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10419,,,3492747,[],CHEMBL1262600,Antimicrobial activity against Staphylococcus aureus NRS120 clinical isolate harboring G2576U mutation in 23S rRNA by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10420,,,3492748,[],CHEMBL1262601,Antimicrobial activity against Staphylococcus aureus NRS121 clinical isolate harboring G2576U mutation in 23S rRNA by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1255265,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961179,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10421,,,3542878,[],CHEMBL1284919,Antimicrobial activity against Staphylococcus aureus IV20204009 harboring vgaAv positive Tn5406 transposon,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10422,,,3542879,[],CHEMBL1284920,Antimicrobial activity against Staphylococcus aureus IV20205004 harboring vgaAv positive Tn5406 transposon,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
10423,,,3542880,[],CHEMBL1284921,Antimicrobial activity against Staphylococcus aureus IV20217008 harboring vgaAv positive Tn5406 transposon,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10424,,,3542881,[],CHEMBL1284922,Antimicrobial activity against Staphylococcus aureus IV20217033 harboring vgaA positive plasmid VGA,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10425,,,3542882,[],CHEMBL1284923,Antimicrobial activity against Staphylococcus aureus IV20222009 harboring vgaAv positive Tn5406 transposon,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
10426,,Not Determined,3542883,[],CHEMBL1284924,Antimicrobial activity against Staphylococcus aureus IHMA127277 harboring vgaAv positive Tn5406 transposon,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,970444,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
10427,,,3542890,[],CHEMBL1284925,Antimicrobial activity against Staphylococcus aureus RN4220,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10428,,,3542891,[],CHEMBL1284926,Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid VGA,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10429,,,3542892,[],CHEMBL1284927,Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid CU1,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10430,,,3542893,[],CHEMBL1284928,Antimicrobial activity against Staphylococcus aureus RN4220 harboring vgaAv positive plasmid CU1,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10431,,,3542894,[],CHEMBL1284929,Antimicrobial activity against Staphylococcus aureus RN1024,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
10432,,,3542895,[],CHEMBL1284930,Antimicrobial activity against Staphylococcus aureus RN1024-tms,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10433,,,3542896,[],CHEMBL1284931,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1275563,Antimicrob Agents Chemother,2008.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970444,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10434,,,5092102,[],CHEMBL1634386,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ST398 expressing cfr, fexA, erm(A), tet(M) and mecA genes",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1629628,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315143,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10435,,,5092103,[],CHEMBL1634387,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ST9 expressing cfr, fexA and erm(C) genes",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1629628,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315143,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10436,,,5092104,[],CHEMBL1634388,Antimicrobial activity against Staphylococcus aureus RN4220,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1629628,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315143,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.063
10437,,,5092105,[],CHEMBL1634389,Antimicrobial activity against Staphylococcus aureus RN4220 transformed with Staphylococcus aureus ST398 plasmid pSCFS3 carrying cfr and fexA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1629628,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315143,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10438,,,5092106,[],CHEMBL1634390,Antimicrobial activity against Staphylococcus aureus RN4220 transformed with Staphylococcus aureus ST9 plasmid pSCFS3 carrying cfr and fexA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1629628,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315143,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10439,,,5163384,[],CHEMBL1667245,Antibacterial activity against Staphylococcus aureus RN4220 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327075,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
10440,,,5163385,[],CHEMBL1667246,"Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD, tet(L), dfrK and vga(C) gene by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327075,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10441,,,5163386,[],CHEMBL1667247,"Antibacterial activity against Staphylococcus aureus RN4220 harboring tet(L), dfrK gene by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327075,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
10442,,,5163387,[],CHEMBL1667248,Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD and tet(L) gene by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327075,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
10443,,,5175229,[],CHEMBL1654786,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by CLSI broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649297,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323363,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10444,,,5175230,[],CHEMBL1654787,Antibacterial activity against Staphylococcus aureus NARSA NRS127 harboring rplC T433 to T435 and L3 Ser145 deletion mutant by CLSI broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649297,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323363,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10445,,,5175231,[],CHEMBL1654785,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 12228 by CLSI broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649297,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323363,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
10446,,,5175232,[],CHEMBL1654784,"Antibacterial activity against Staphylococcus epidermidis 1653059 harboring rplC G469A/C470G, L3 Ala157Arg and 23S rRNA G2447T mutant by CLSI broth microdilution assay",F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649297,Antimicrob Agents Chemother,2009.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323363,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
10447,,,5183838,[],CHEMBL1664540,Antimicrobial activity against Bacillus sp. BS-01 expressing multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces,F,,,BAO_0002146,BAO_0000221,tissue-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323814,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,256.0
10448,,,5183848,[],CHEMBL1664541,Antimicrobial activity against Staphylococcus aureus RN4220 harboring pBS-01multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323814,<,1,1,<,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10449,,,5183858,[],CHEMBL1664542,Antimicrobial activity against Staphylococcus aureus RN4220,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323814,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10450,,,5298808,[],CHEMBL1689987,Antibacterial activity against methicillin-resistant Staphylococcus aureus M05/0060 harboring cfr-encoding conjugative pSCFS7 and fexA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338425,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10451,,,5298809,[],CHEMBL1689986,Antibacterial activity against pSCFS7-deficient methicillin-resistant Staphylococcus aureus M05/0060-C1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338425,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10452,,,5298810,[],CHEMBL1689984,Antibacterial activity against Staphylococcus aureus XU21 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338425,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10453,,,5298811,[],CHEMBL1689985,Antibacterial activity against Staphylococcus aureus XU21-T1 harboring cfr-encoding conjugative pSCFS7 and fexA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687819,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338425,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
10454,,,5315386,[],CHEMBL1691858,Antibacterial activity against clinical-derived Staphylococcus aureus isolate 42262 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10455,,,5315387,[],CHEMBL1691859,Antibacterial activity against clinical-derived Staphylococcus aureus isolate harboring ribosomal protein L3 deltaSer145/His146Tyr mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10456,,,5315388,[],CHEMBL1692007,Antibacterial activity against clinical-derived Staphylococcus aureus isolate 51312 harboring ribosomal protein L3 deltaMet169-Gly174 mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10457,,,5315389,[],CHEMBL1692008,Antibacterial activity against laboratory-derived Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10458,,,5315390,[],CHEMBL1690230,Antibacterial activity against laboratory-derived Staphylococcus aureus isolate 29213-1 harboring ribosomal protein L3 Gly155Arg mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
10459,,,5315391,[],CHEMBL1690231,Antibacterial activity against laboratory-derived Staphylococcus aureus isolate 29213-2 harboring ribosomal protein L3 Gly155Arg/Met169Leu mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10460,,,5315392,[],CHEMBL1690232,Antibacterial activity against laboratory-derived Staphylococcus aureus isolate 29213-3 harboring ribosomal protein L3 deltaPhe127-His146 mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
10461,,,5315393,[],CHEMBL1690233,Antibacterial activity against laboratory-derived Staphylococcus aureus ATCC 29213 harboring cfr-containing p42262 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10462,,,5315394,[],CHEMBL1690234,Antibacterial activity against laboratory-derived Staphylococcus aureus isolate 29213-1 harboring ribosomal protein L3 Gly155Arg mutant and cfr-containing p42262 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10463,,,5315395,[],CHEMBL1690235,Antibacterial activity against laboratory-derived Staphylococcus aureus isolate 29213-2 harboring ribosomal protein L3 Gly155Arg/Met169Leu mutant and cfr-containing p42262 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10464,,,5315396,[],CHEMBL1690236,Antibacterial activity against laboratory-derived Staphylococcus aureus isolate 29213-3 harboring ribosomal protein L3 deltaPhe127-His146 mutant and cfr-containing p42262 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL1687803,Antimicrob Agents Chemother,2010.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338164,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
10465,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [+],10997132,[],CHEMBL2075513,"TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 1.9 uM, Tiamulin: 2 uM) in CEM/VLB3.6 cells, flow cytometry",F,,,BAO_0000375,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2074472,Biochem Pharmacol,1998.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,1669003,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
10466,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [+],10997987,[],CHEMBL2077387,"TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 1.9 uM, Tiamulin: 2 uM) in P388/ADR25 cells, flow cytometry",F,,,BAO_0000375,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2074472,Biochem Pharmacol,1998.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,1669003,,18,0,,,Activity,,,,CHEMBL2573,Mus musculus,P-glycoprotein 3,10090.0,,,Activity,,,,
10467,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [+],10997988,[],CHEMBL2078340,"TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 1.9 uM, Tiamulin: 2 uM) in AS30-D/COL10 cells, flow cytometry",F,,,BAO_0000375,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2074472,Biochem Pharmacol,1998.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,1669003,,18,0,,,Activity,,,,CHEMBL1075135,Rattus norvegicus,Multidrug resistance protein 1a,10116.0,,,Activity,,,,
10468,,,11004747,[],CHEMBL2089902,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate cpu0211 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10469,,,11004757,[],CHEMBL2089903,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate cpu0587 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
10470,,,11004767,[],CHEMBL2089904,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate cpu1044 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
10471,,,11004777,[],CHEMBL2089905,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate cpu1344 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10472,,,11004787,[],CHEMBL2089906,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate cpu0446 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10473,,,11004797,[],CHEMBL2089907,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate cpu0887 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10474,,,11004807,[],CHEMBL2089908,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate cpu1098 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10475,,,11004817,[],CHEMBL2089909,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate cpu3256 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10476,,,11004827,[],CHEMBL2089910,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate cpu0315 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.0625
10477,,,11004837,[],CHEMBL2089911,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate cpu0347 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
10478,,,11004847,[],CHEMBL2089912,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate cpu2089 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
10479,,,11004857,[],CHEMBL2089913,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate cpu1561 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.0625
10480,,,11004867,[],CHEMBL2089914,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate cpu2623 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
10481,,,11004877,[],CHEMBL2089915,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate cpu3889 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
10482,,,11004887,[],CHEMBL2089916,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate cpu3569 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
10483,,,11004897,[],CHEMBL2089917,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate cpu2736 after 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.0625
10484,,,11004930,[],CHEMBL2091583,Antimicrobial activity against Mycoplasma by serial two fold dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086231,Bioorg Med Chem Lett,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1675257,<,1,1,<,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
10485,,,11011659,[],CHEMBL2089643,Binding affinity to Escherichia coli 23S rRNA U2506 assessed as degree of protection against CMCT at 5 uM by Chemical footprinting analysis relative to control,B,,,BAO_0000193,BAO_0000225,nucleic acid format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086327,J Med Chem,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,1673376,=,1,0,=,,Ratio,,,0.07,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,0.07
10486,,,11011674,[],CHEMBL2089644,Binding affinity to Escherichia coli 23S rRNA U2506 assessed as degree of protection against CMCT at 50 uM by Chemical footprinting analysis relative to control,B,,,BAO_0000193,BAO_0000225,nucleic acid format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086327,J Med Chem,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,1673376,=,1,0,=,,Ratio,,,0.03,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,0.03
10487,,,11011689,[],CHEMBL2089645,Binding affinity to Escherichia coli 23S rRNA U2585 assessed as degree of protection against CMCT at 5 uM by Chemical footprinting analysis relative to control,B,,,BAO_0000193,BAO_0000225,nucleic acid format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086327,J Med Chem,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,1673376,=,1,0,=,,Ratio,,,0.54,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,0.54
10488,,,11011704,[],CHEMBL2089646,Binding affinity to Escherichia coli 23S rRNA U2585 assessed as degree of protection against CMCT at 50 uM by Chemical footprinting analysis relative to control,B,,,BAO_0000193,BAO_0000225,nucleic acid format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086327,J Med Chem,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,1673376,=,1,0,=,,Ratio,,,0.5,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,0.5
10489,,,11011719,[],CHEMBL2089647,Antibacterial activity against Escherichia coli AS19 after 24 hrs by microtitre plate reader,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086327,J Med Chem,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1673376,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
10490,,,11011734,[],CHEMBL2089648,Antibacterial activity against Listeria innocua after 24 hrs by microtitre plate reader,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086327,J Med Chem,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1673376,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612636,Listeria innocua,Listeria innocua,1642.0,,,MIC,ug ml-1,UO_0000274,,32.0
10491,,,11011749,[],CHEMBL2089649,Antibacterial activity against Bacillus subtilis 168 after 12 hrs by microtitre plate reader,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL2086327,J Med Chem,2012.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1673376,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,32.0
10492,,,17969602,[],CHEMBL3995656,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL3994615,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2977576,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10493,,,17969625,[],CHEMBL3995657,Antibacterial activity against Staphylococcus aureus ATCC 29213 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL3994615,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2977576,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10494,,,17969648,[],CHEMBL3995658,Antibacterial activity against Enterococcus faecalis ATCC 29212 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL3994615,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2977576,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
10495,,,17969670,[],CHEMBL3995659,Antibacterial activity against Enterococcus faecium ATCC 35667 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL3994615,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2977576,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
10496,,,17969675,[],CHEMBL3995660,"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 infected in neutropenic mouse assessed as mouse survival rate at 40 mg/kg, iv administered 1 hr post infection relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL3994615,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Percent,2977576,=,1,0,=,,Survival,%,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Survival,%,UO_0000187,,10.0
10497,,,18006453,[],CHEMBL4003334,Antibacterial activity against Staphylococcus aureus CMCC (B) 26003 after 24 to 48 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2983845,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
10498,,,18006464,[],CHEMBL4003333,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 24 to 48 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2983845,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
10499,,,18006475,[],CHEMBL4003332,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 after 24 to 48 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2983845,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10500,,,18006496,[],CHEMBL4003335,Antibacterial activity against Bacillus subtilis CMCC (B) 63501 after 24 to 48 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2983845,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
10501,,,18006507,[],CHEMBL4003336,Antibacterial activity against Escherichia coli CMCC (B) 44102 after 24 to 48 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2983845,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
10502,,,18006518,[],CHEMBL4003337,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 at 320 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,29.45,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,29.45
10503,,,18006529,[],CHEMBL4003338,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 at 160 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,22.94,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,22.94
10504,,,18006540,[],CHEMBL4003339,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 at 320 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,33.88,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,33.88
10505,,,18006551,[],CHEMBL4003340,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 at 160 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,20.21,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,20.21
10506,,,18006562,[],CHEMBL4003341,Antibacterial activity against Staphylococcus aureus CMCC (B) 26003 at 320 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,37.88,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,37.88
10507,,,18006573,[],CHEMBL4003342,Antibacterial activity against Staphylococcus aureus CMCC (B) 26003 at 160 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,26.14,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,26.14
10508,,,18006584,[],CHEMBL4003343,Antibacterial activity against Bacillus subtilis CMCC (B) 63501 at 320 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,21.33,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,21.33
10509,,,18006595,[],CHEMBL4003344,Antibacterial activity against Bacillus subtilis CMCC (B) 63501 at 160 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,17.45,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,17.45
10510,,,18006606,[],CHEMBL4003345,Antibacterial activity against Escherichia coli CMCC (B) 44102 at 320 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,13.28,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,13.28
10511,,,18006617,[],CHEMBL4003346,Antibacterial activity against Escherichia coli CMCC (B) 44102 at 160 ug/ml after 24 to 36 hrs by oxford cup assay,F,,,BAO_0003039,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Millimeter,2983845,=,1,1,=,,IZ,mm,,9.42,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,9.42
10512,,Dose-dependent effect,18006619,[],CHEMBL4003347,Bactericidal activity against Staphylococcus aureus CMCC (B) 26003 after 1 to 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10513,,,18006621,[],CHEMBL4003348,Bactericidal activity against Staphylococcus aureus CMCC (B) 26003 at 6 times MIC after 4 hrs by time-kill assay relative to control,F,,,BAO_0000179,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,>,1,0,>,,FC,,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,6.0
10514,,,18006623,[],CHEMBL4003349,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 29213 at 6 times MIC after 4 hrs by time-kill assay relative to control,F,,,BAO_0000179,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,>,1,0,>,,FC,,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,6.0
10515,,,18006625,[],CHEMBL4003350,Bactericidal activity against Staphylococcus aureus CMCC (B) 26003 assessed as bacterial level at MIC after 1 to 24 hrs by time-kill assay,F,,,BAO_0000181,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,=,1,0,=,,Activity,log10CFU/ml,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,4.0,3.0
10516,,,18006627,[],CHEMBL4003351,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 29213 assessed as bacterial level at MIC after 1 to 24 hrs by time-kill assay,F,,,BAO_0000181,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,=,1,0,=,,Activity,log10CFU/ml,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,4.0,3.0
10517,,Dose-dependent effect,18006629,[],CHEMBL4003352,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 29213 after 1 to 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10518,,Dose-dependent effect,18006632,[],CHEMBL4003354,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 in iv dosed Balb/c mouse systemic infection model assessed as increase in mouse survival after 7 days,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10519,,,18006634,[],CHEMBL4003354,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 in iv dosed Balb/c mouse systemic infection model assessed as increase in mouse survival after 7 days,F,,,BAO_0003036,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4002584,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,2983845,=,1,1,=,,ED50,mg.kg-1,,5.94,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,5.94
10520,,,18512010,[],CHEMBL4192004,Inhibition of P-gp ATPase activity in rat AS30-D/COL10 cell plasma membrane vesicles,B,,,BAO_0000190,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4190243,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,6.27,0,http://www.openphacts.org/units/Nanomolar,3073503,=,1,1,=,,IC50,nM,,540.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.54
10521,,,18512048,[],CHEMBL4192037,"Potentiation of doxorubicin-induced antitumor activity against mouse P388/DOX25 cells implanted in mouse assessed as increase in mouse survival at 1.6 mg/kg, ip",F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4190243,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Percent,3073503,=,1,0,=,,Survival,%,,29.0,CHEMBL389,Mus musculus,P388,10090.0,,,Survival,%,UO_0000187,,29.0
10522,,,18512049,[],CHEMBL4192038,Inhibition of P-gp in rat AS30-D/COL10 cell plasma membrane vesicles assessed as reduction in [3H]VBL transport,B,,,BAO_0000190,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4190243,Eur J Med Chem,2017.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,5.21,0,http://www.openphacts.org/units/Nanomolar,3073503,=,1,1,=,,IC50,nM,,6200.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,6.2
10523,,,19075531,[],CHEMBL4362768,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition incubated for 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3182621,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10524,,,19075554,[],CHEMBL4362767,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition incubated for 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3182621,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10525,,,19075577,[],CHEMBL4362769,Antibacterial activity against Staphylococcus aureus AD3 assessed as bacterial growth inhibition incubated for 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3182621,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10526,,,19075625,[],CHEMBL4362766,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as reduction in colony forming unit at 4 times MIC incubated for 3 hrs followed by compound dilution with saline and then incubated for 20 hrs on MH agar plate by time-kill kinetics assay,F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3182621,=,1,0,=,,Activity,log10CFU/ml,,1.54,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,1.54
10527,,,19075626,[],CHEMBL4362772,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as reduction in colony forming unit at 4 times MIC incubated for 24 hrs followed by compound dilution with saline and then incubated for 20 hrs on MH agar plate by time-kill kinetics assay,F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3182621,=,1,0,=,,Activity,log10CFU/ml,,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,1.9
10528,,,19075628,[],CHEMBL4362774,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as reduction in colony forming unit at 4 times MIC incubated for 3 hrs followed by compound dilution with saline and then incubated for 20 hrs on MH agar plate by time-kill kinetics assay relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Percent,3182621,=,1,0,=,,Activity,%,,97.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,97.0
10529,,,19075631,[],CHEMBL4362776,Antibacterial against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibiotic effect time at 2 times MIC incubated for 1 hr followed by compound washout and then incubated for 20 hrs onto MH agar plate,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3182621,=,1,1,=,,TIME,hr,,1.53,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,1.53
10530,,,19075633,[],CHEMBL4362777,Antibacterial against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibiotic effect time at 4 times MIC incubated for 1 hr followed by compound washout and then incubated for 20 hrs onto MH agar plate,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3182621,=,1,1,=,,TIME,hr,,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,1.9
10531,,,19075635,[],CHEMBL4362778,Antibacterial against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibiotic effect time at 2 times MIC incubated for 2 hrs followed by compound washout and and then incubated for 20 hrs onto MH agar plate,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3182621,=,1,1,=,,TIME,hr,,1.65,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,1.65
10532,,,19075637,[],CHEMBL4362779,Antibacterial against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibiotic effect time at 4 times MIC incubated for 2 hrs followed by compound washout and and then incubated for 20 hrs onto MH agar plate,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3182621,=,1,1,=,,TIME,hr,,2.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,2.04
10533,,,19075646,[],CHEMBL4362787,"Antibacterial activity against methicillin-resistant Staphylococcus aureus infected in neutropenic thigh infection ICR/Swiss mouse model assessed reduction in colony forming unit in thigh at 20 mg/kg, iv administered 2 hrs post infection and measured at 24 hrs after drug dosage",F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3182621,=,1,0,=,,Activity,log10CFU/ml,,0.59,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,0.59
10534,,,19075648,[],CHEMBL4362788,"Antibacterial activity against methicillin-resistant Staphylococcus aureus infected in systemic infection ICR mouse model assessed as animal survival rate at 30 mg/kg, iv relative to control",F,,,BAO_0001103,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4359884,Eur J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Percent,3182621,=,1,0,=,,Activity,%,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,20.0
10535,,,19484919,[],CHEMBL4481393,Antimicrobial activity against Wolbachia pipientis infected in Asian tiger mosquito C6/36 cells after 7 days by SYTO11 DNA dye-based confocal imaging analysis,F,,,BAO_0000188,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4480405,J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,6.5,0,http://www.openphacts.org/units/Nanomolar,3258546,=,1,1,=,,EC50,nM,,317.0,CHEMBL4630676,Wolbachia,Wolbachia,953.0,,,EC50,nM,UO_0000065,,317.0
10536,,,19484946,[],CHEMBL4481394,Antimicrobial activity against Wolbachia wMel infected in Drosophila melanogaster LDW1 cells after 6 days by DAPI-based fluorescence in-situ hybridization assay,F,,,BAO_0000188,BAO_0000019,assay format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4480405,J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,6.22,0,http://www.openphacts.org/units/Nanomolar,3258546,=,1,1,=,,EC50,nM,,606.0,CHEMBL4630676,Wolbachia,Wolbachia,953.0,,,EC50,nM,UO_0000065,,606.0
10537,,,19485016,[],CHEMBL4481395,Intrinsic clearance in mouse liver S9 fraction,A,,,BAO_0002759,BAO_0000220,subcellular format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4480405,J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3258546,=,1,1,=,,CL,mL.min-1.g-1,,131.0,CHEMBL612558,,ADMET,,,,CLH,microL/min/mg,,,131.0
10538,,,19485072,[],CHEMBL4481397,Fraction unbound in mouse plasma at 1 uM,A,,,BAO_0000179,BAO_0000366,cell-free format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4480405,J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3258546,=,1,1,=,,Fu,,,0.26,CHEMBL612558,,ADMET,,,,Fu,,,,0.26
10539,,,19485076,[],CHEMBL4481398,Apparent permeability of the compound in MDCK-MDR1 cells,A,,,BAO_0002808,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4480405,J Med Chem,2019.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3258546,=,1,0,=,,Papp,10'-6 cm/s,,22.1,CHEMBL612558,,ADMET,,,,Papp,10'-6 cm/s,,,22.1
10540,,,22790586,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709404,Antibacterial activity against Staphylococcus aureus ATCC 25923 measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,820.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.82
10541,,,22790607,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709405,Antibacterial activity against Staphylococcus epidermidis ATCC 51625 measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,820.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,0.82
10542,,,22790628,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709406,Antibacterial activity against Staphylococcus aureus BNCC 337371 measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,820.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.82
10543,,,22790649,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709407,Antibacterial activity against Streptococcus dysgalactiae measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,200.0,CHEMBL1075341,Streptococcus dysgalactiae,Streptococcus dysgalactiae,1334.0,,,MIC,uM,UO_0000065,,0.2
10544,,,22790670,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709408,Antibacterial activity against Streptococcus agalactiae measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,200.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,uM,UO_0000065,,0.2
10545,,,22790691,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709409,Antibacterial activity against Enterococcus faecalis measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,52480.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,52.48
10546,,,22790712,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709410,Antibacterial activity against Pasteurella multocida CVCC 1659 measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,3280.0,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,uM,UO_0000065,,3.28
10547,,,22790733,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4709411,Antibacterial activity against Escherichia coli CICC 10389 measured after 18 to 24 hrs by microtiter dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3538864,=,1,1,=,,MIC,nM,,52480.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,52.48
10548,,Dose-dependent effect,22790737,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '2.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '2.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '48.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4709412,Bacteriostatic activity against Staphylococcus aureus BNCC 337371 assessed as reduction in bacterial load incubated for 2 to 24 hrs prior to 10 fold dilution followed by replating on MH agar plate and measured after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10549,,,22790740,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '32.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '32.0'}]",CHEMBL4709413,Bacteriostatic activity against Staphylococcus aureus BNCC 337371 assessed as reduction in bacterial load at 2 to 4 times MIC incubated for 8 hrs prior to 10 fold dilution followed by replating on MH agar plate and measured after 24 hrs by time-kill assay relative to control,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,=,1,0,=,,FC,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,1.0
10550,,Dose-dependent effect,22790742,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4709414,Antibacterial activity against Staphylococcus aureus BNCC 337371 infected in ip dosed Kunming mouse assessed as increase in mouse survival measured after 7 days,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10551,,,22790744,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4709414,Antibacterial activity against Staphylococcus aureus BNCC 337371 infected in ip dosed Kunming mouse assessed as increase in mouse survival measured after 7 days,F,,,BAO_0003036,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,=,1,1,=,,ED50,mg.kg-1,,25.85,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,25.85
10552,,,22790746,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'mg/kg', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Lower', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'mg/kg', 'standard_value': '40.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'mg/kg', 'value': '40.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '2.0'}]",CHEMBL4709416,"Antibacterial activity against Staphylococcus aureus BNCC 337371 infected in Kunming mouse assessed as bacterial load in lung at 20 to 40 mg/kg, ip measured after 2 days by colony counting method (Rvb = 4.8 log10CFU/ml)",F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,=,1,0,=,,Activity,log10CFU/ml,,1.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,1.1
10553,,Not Active,22790749,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'mg/kg', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Lower', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'mg/kg', 'standard_value': '40.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'mg/kg', 'value': '40.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '2.0'}]",CHEMBL4709418,"Antibacterial activity against Staphylococcus aureus BNCC 337371 infected in Kunming mouse assessed as reduction in bacterial load in liver at 20 to 40 mg/kg, ip measured after 2 days by colony counting method",F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10554,,Active,22790753,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'mg/kg', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Lower', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'mg/kg', 'standard_value': '40.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'mg/kg', 'value': '40.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '2.0'}]",CHEMBL4709422,"Antibacterial activity against Staphylococcus aureus BNCC 337371 infected in Kunming mouse assessed as reduction in infiltration of neutrophils cells at 20 to 40 mg/kg, ip measured after 2 days by H and E staining based light microscopic analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10555,,Active,22790754,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'mg/kg', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Lower', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'mg/kg', 'standard_value': '40.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'mg/kg', 'value': '40.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '2.0'}]",CHEMBL4709423,"Antibacterial activity against Staphylococcus aureus BNCC 337371 infected in Kunming mouse assessed as reduction in local congestion in lung at 20 to 40 mg/kg, ip measured after 2 days by H and E staining based light microscopic analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4706538,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3538864,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10556,,,22981867,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4773099,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by CLSI based broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10557,,,22981896,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4773100,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by CLSI based broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10558,,,22981925,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4773101,Antibacterial activity against Staphylococcus aureus AD3 after 24 hrs by CLSI based broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10559,,,22981954,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4773102,Antibacterial activity against Staphylococcus aureus 144 after 24 hrs by CLSI based broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10560,,,22982010,[],CHEMBL4773104,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 43300 preincubated 16 to 20 hrs followed by subculturing and measured after over night,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
10561,,,22982039,[],CHEMBL4773105,Bactericidal activity against Staphylococcus aureus ATCC 29213 preincubated 16 to 20 hrs followed by subculturing and measured after over night,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
10562,,,22982068,[],CHEMBL4773106,Bactericidal activity against Staphylococcus aureus AD3 preincubated 16 to 20 hrs followed by subculturing and measured after over night,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
10563,,,22982097,[],CHEMBL4773107,Bactericidal activity against Staphylococcus aureus 144 preincubated 16 to 20 hrs followed by subculturing and measured after over night,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3569087,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
10564,,,22982160,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4773113,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibacterial effect at 2 time of MIC concentration preincubated for 2 hrs followed by compound washout further incubated with fresh medium and measured for 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3569087,=,1,0,=,,PAE,hr,,1.65,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.65
10565,,,22982163,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4773114,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibacterial effect at 4 time of MIC concentration preincubated for 2 hrs followed by compound washout further incubated with fresh medium and measured for 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3569087,=,1,0,=,,PAE,hr,,2.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.04
10566,,,22982165,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4773115,"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 infected in ICR/Swiss mouse model of neutropenic thigh infection assessed as reduction in bacterial load at 20 mg/kg, iv and measured after 24 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3569087,=,1,0,=,,Activity,log10CFU/g,,0.77,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/g,,,0.77
10567,,,22982167,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '30.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '30.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4773116,"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 infected in ICR/Swiss mouse systemic infection model assessed as survival rate at 30 mg/kg, ip after 7 days relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4765405,Eur J Med Chem,2020.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Percent,3569087,=,1,0,=,,Survival,%,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Survival,%,UO_0000187,,20.0
10568,,,23190710,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4818561,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of visible growth incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606316,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10569,,,23190732,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4818562,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of visible growth incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606316,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10570,,,23190754,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4818563,Antibacterial activity against Staphylococcus aureus 144 assessed as inhibition of visible growth incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606316,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10571,,,23190776,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4818564,Antibacterial activity against Staphylococcus aureus AD3 assessed as inhibition of visible growth incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606316,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10572,,,23190786,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4818567,"In vivo antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 infected in ICR/Swiss mouse model of neutropenic thigh infection assessed as reduction in bacterial growth at 20 mg/kg, iv administered 2 hrs after infection and tissue collected after 24 hrs and measured after 24 hrs by broth microdilution method",F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3606316,=,1,0,=,,Activity,log10CFU/g,,0.91,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/g,,,0.91
10573,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23190789,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL4818569,Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate incubated for 5 mins followed by NADPH addition and measured after 5 mins by LC/MS/MS analysis,B,,,BAO_0000190,BAO_0000251,microsome format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,"{'bei': '11.74', 'le': '0.23', 'lle': '0.83', 'sei': '8.67'}",CHEMBL1234521,TIAMULIN,CHEMBL1234521,5.8,0,http://www.openphacts.org/units/Nanomolar,3606316,=,1,1,=,,IC50,nM,,1600.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,uM,UO_0000065,,1.6
10574,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,23190798,[],CHEMBL4818571,Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosome assessed as association constant by SPR analysis,B,,,BAO_0002809,BAO_0000220,subcellular format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3606316,=,1,0,=,,Ka,10^1/Ms,,1.21,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Ka,10^1/Ms,,,1.21
10575,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,23190807,[],CHEMBL4818572,Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosome assessed as dissociation constant by SPR analysis,B,,,BAO_0000034,BAO_0000220,subcellular format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3606316,=,1,0,=,,Kd,10^-6/s,,3.03,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Kd,10^-6/s,,,3.03
10576,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,23190816,[],CHEMBL4818573,Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosome assessed as dissociation rate constant by SPR analysis,B,,,BAO_0000179,BAO_0000220,subcellular format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4814060,Bioorg Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3606316,=,1,0,=,,Kdiss,10^-8M,,2.5,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Kdiss,10^-8M,,,2.5
10577,,,23254815,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4831835,Antibacterial activity against Methycillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10578,,,23254842,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4831836,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10579,,,23254869,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4831837,Antibacterial activity against Staphylococcus aureus AD3 assessed as inhibition of bacterial growth measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10580,,,23254896,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4831838,Antibacterial activity against Staphylococcus aureus 144 assessed as inhibition of bacterial growth measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10581,,,23254923,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4831839,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
10582,,,23254950,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL4831840,Bactericidal activity against Methycillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth measured after 96 hrs by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
10583,,,23254977,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL4831841,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth measured after 96 hrs by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
10584,,,23255004,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL4831842,Bactericidal activity against Staphylococcus aureus AD3 assessed as inhibition of bacterial growth measured after 96 hrs by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
10585,,,23255031,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL4831843,Bactericidal activity against Staphylococcus aureus 144 assessed as inhibition of bacterial growth measured after 96 hrs by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
10586,,,23255058,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '96.0'}]",CHEMBL4831844,Bactericidal activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 96 hrs by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,>,1,0,>,,MBC,ug ml-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,64.0
10587,,,23255065,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4831851,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibiotic effect by measuring time required for increase in 1 log10 CFU/ml of bacteria at 2X MIC incubated for 2 hrs followed by compound washout and measured after 20 hrs by time-kill assay (Rvb = 2.44 hrs),F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3617691,=,1,1,=,,TIME,hr,,1.72,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,1.72
10588,,,23255066,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4831852,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as post antibiotic effect by measuring time required for increase in 1 log10 CFU/ml of bacteria at 4X MIC incubated for 2 hrs followed by compound washout and measured after 20 hrs by time-kill assay (Rvb = 2.44 hrs),F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Hour,3617691,=,1,1,=,,TIME,hr,,2.14,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,2.14
10589,,,23255068,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4831853,"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 infected in neutropenic CD1 mouse model of thigh infection assessed as reduction in bacterial colony forming unit in thigh at 20 mg/kg, iv qd measured after 24 hrs relative to control",F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3617691,=,1,0,=,,Activity,log10CFU/ml,,-1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,-1.4
10590,,,23255119,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4831856,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth measured after 8 passages at sub-MIC concentration incubated for 24 hrs by resistant development assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL4831486,Eur J Med Chem,2021.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3617691,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10591,,,24758706,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5123244,Antibacterial activity against Staphylococcus aureus assessed as diameter of the inhibition circle at 1 mg/ml incubated for 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5120839,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Millimolar,3862835,=,1,0,=,,Activity,mM,,25.21,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mM,UO_0000063,,25.21
10592,,,24758742,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5123245,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth two-fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5120839,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862835,=,1,1,=,,MIC,ug.mL-1,,0.4883,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.4883
10593,,,24758778,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5123246,Antibacterial activity against Streptococcus agalactiae assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth two-fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5120839,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862835,=,1,1,=,,MIC,ug.mL-1,,0.1221,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.1221
10594,,,24758814,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5123247,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth two-fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5120839,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862835,=,1,1,=,,MIC,ug.mL-1,,15.62,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,15.625
10595,,,24758821,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5123248,Antibacterial activity against Methicillin-resistant Staphylococcus aureus BNCC 337371 assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth two-fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5120839,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862835,=,1,1,=,,MIC,ug.mL-1,,0.4883,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.4883
10596,,Active,24758845,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5123254,Bactericidal activity against Staphylococcus aureus assessed as bacterial killing at 8 times MIC incubated up to 24 hrs by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5120839,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3862835,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10597,,,24816316,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5138708,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 16 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3875284,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10598,,,24816335,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5138709,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 16 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3875284,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10599,,,24816354,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5138710,Antibacterial activity against Staphylococcus aureus AD3 assessed as inhibition of bacterial growth incubated for 16 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3875284,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10600,,,24816373,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5138711,Antibacterial activity against Staphylococcus aureus 144 assessed as inhibition of bacterial growth incubated for 16 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3875284,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10601,,,24816392,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5138712,Antibacterial activity against Staphylococcus aureus SA17 assessed as inhibition of bacterial growth incubated for 16 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3875284,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10602,,,24816405,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '20.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IV', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IV', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5138716,"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 infected in ICR/Swiss mouse neuropathic thigh infection model assessed as log reduction in bacterial load in thigh at 20 mg/kg, iv administered as bolus injection measured after 24 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3875284,=,1,0,=,,Activity,log10CFU/ml,,-1.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,-1.1
10603,,,24816407,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '30.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '30.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IV', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IV', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'day', 'standard_value': '2.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'day', 'value': '2.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'day', 'standard_value': '7.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'day', 'value': '7.0'}]",CHEMBL5138718,"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 infected in ICR/Swiss mouse systemic infection model assessed as survival rate at 30 mg/kg, iv administered as bolus injection 1 hr post infection measured twice daily after 2 to 7 days",F,,,BAO_0000179,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://qudt.org/vocab/unit#Percent,3875284,=,1,0,=,,Survival,%,,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Survival,%,UO_0000187,,30.0
10604,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24816415,[],CHEMBL5138724,Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosomal subunit assessed as association rate constant by surface plasmon resonance analysis,B,,,BAO_0002809,BAO_0000220,subcellular format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3875284,=,1,0,=,,Ka,10^2/Ms,,1.22,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Ka,10^2/Ms,,,1.22
10605,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24816419,[],CHEMBL5138725,Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosomal subunit assessed as dissociation constant by surface plasmon resonance analysis,B,,,BAO_0000034,BAO_0000220,subcellular format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3875284,=,1,0,=,,Kd,10^-6/s,,4.44,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Kd,10^-6/s,,,4.44
10606,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24816423,[],CHEMBL5138726,Binding affinity to Staphylococcus aureus ATCC 43300 50S ribosomal subunit assessed as equilibrium dissociation constant by surface plasmon resonance analysis,B,,,BAO_0000034,BAO_0000220,subcellular format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5137011,Eur J Med Chem,2022.0,"{'bei': '15.07', 'le': '0.30', 'lle': '2.47', 'sei': '11.13'}",CHEMBL1234521,TIAMULIN,CHEMBL1234521,7.44,0,http://www.openphacts.org/units/Nanomolar,3875284,=,1,1,=,,Kd,nM,,36.3,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,,Kd,10^-8M,UO_0000065,,3.63
10607,,,24843336,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146045,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 18 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880534,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
10608,,,24843370,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146046,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 18 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880534,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
10609,,,24843404,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146047,Antibacterial activity against Enterococcus faecium ATCC19434 assessed as inhibition of bacterial growth incubated for 18 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
10610,,,24843438,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146048,Antibacterial activity against Staphylococcus epidermidis ATCC12228 assessed as inhibition of bacterial growth incubated for 18 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880534,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
10611,,Active,24843464,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146053,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 43300 at 4 times MIC and measured after 24 hrs by time kill curve assay relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3880534,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10612,,,24843473,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5146054,Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3880534,>,1,1,>,,IC50,nM,,10000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,umol/L,UO_0000065,,10.0
10613,,,24843482,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5146055,Cytotoxicity against human U87 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3880534,>,1,1,>,,IC50,nM,,10000.0,CHEMBL614247,Homo sapiens,U-87 MG,9606.0,,,IC50,umol/L,UO_0000065,,10.0
10614,,,24843491,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5146056,Cytotoxicity against human HGC-27 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3880534,>,1,1,>,,IC50,nM,,10000.0,CHEMBL1075463,Homo sapiens,HGC-27,9606.0,,,IC50,umol/L,UO_0000065,,10.0
10615,,,24843500,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5146057,Cytotoxicity against human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3880534,>,1,1,>,,IC50,nM,,10000.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,IC50,umol/L,UO_0000065,,10.0
10616,,,24843509,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5146058,Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5143602,Bioorg Med Chem,2022.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/Nanomolar,3880534,>,1,1,>,,IC50,nM,,10000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,umol/L,UO_0000065,,10.0
10617,,,25068922,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252437,Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929437,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10618,,,25068956,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252438,Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929437,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10619,,,25068990,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252439,Antibacterial activity against Methicillin-resistant Staphylococcus epidermidis ATCC 51625 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929437,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
10620,,,25069024,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252440,Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929437,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
10621,,,25069058,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252441,Antibacterial activity against Methicillin-sensitive Staphylococcus epidermidis ATCC 12228 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929437,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
10622,,,25069092,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252442,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929437,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
10623,,Active,25069096,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252443,Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial growth inhibition at 1 to 2 times MIC measured upto 24 hrs by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10624,,Active,25069098,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252444,Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial colony inhibition at 1 to 2 times MIC measured upto 24 hrs by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10625,,Not Active,25069101,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5252446,Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial bactericidal effect at 1 to 2 times MIC measured upto 24 hrs by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10626,,,25069106,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL5252451,"Invivo Antibacterial activity against Methicillin-resistant Staphylococcus aureus in ICR mouse thigh infection model assessed as reduction in bacterial load at 40 mg/kg, IP by hematoxylin and eosin staining based light microscopic analysis",F,,,BAO_0000181,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,=,1,0,=,,Activity,10^7CFU/g,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,10^7CFU/g,,,1.0
10627,,,25069159,[],CHEMBL5252467,Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591,F,,,BAO_0000193,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,=,1,0,=,,Ratio,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,4.0
10628,,,25069193,[],CHEMBL5252468,Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300,F,,,BAO_0000193,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,=,1,0,=,,Ratio,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,4.0
10629,,,25069227,[],CHEMBL5252469,Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus epidermidis ATCC 51625 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus epidermidis ATCC 51625,F,,,BAO_0000193,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,>,1,0,>,,Ratio,,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Ratio,,,,4.0
10630,,,25069261,[],CHEMBL5252470,Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 29213 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 29213,F,,,BAO_0000193,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,>,1,0,>,,Ratio,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,4.0
10631,,,25069295,[],CHEMBL5252471,Selectivity ratio of MBC for antibacterial activity against Methicillin-sensitive Staphylococcus epidermidis ATCC 1228 to MIC for antibacterial activity against Methicillin-sensitive Staphylococcus epidermidis ATCC 1228,F,,,BAO_0000193,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,>,1,0,>,,Ratio,,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Ratio,,,,4.0
10632,,,25069328,[],CHEMBL5252472,Selectivity ratio of MBC for antibacterial activity against Staphylococcus aureus to MIC for antibacterial activity against Staphylococcus aureus,F,,,BAO_0000193,BAO_0000218,organism-based format,C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,,,CHEMBL5247680,ACS Med Chem Lett,2023.0,,CHEMBL1234521,TIAMULIN,CHEMBL1234521,,0,,3929437,=,1,0,=,,Ratio,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,4.0
10633,,,2722411,[],CHEMBL1063603,Antibiotic activity against Bacillus subtilis NBRC 3513 by microplate dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829607,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,6.25
10634,,,2722413,[],CHEMBL1063604,Antibiotic activity against Bacillus megaterium ATCC 19213 by microplate dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829607,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,6.25
10635,,,2722415,[],CHEMBL1063605,Antibiotic activity against Staphylococcus epidermidis NBRC 12933 by microplate dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829607,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,12.5
10636,,,2722417,[],CHEMBL1063606,Antibiotic activity against Staphylococcus aureus NBRC 12732 by microplate dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829607,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
10637,,,2722419,[],CHEMBL1063607,Antibiotic activity against Pseudomonas aeruginosa NBRC 3080 by microplate dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829607,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,100.0
10638,,,2722421,[],CHEMBL1063608,Antibiotic activity against Escherichia coli NBRC 12734 by microplate dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829607,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
10639,,Dose-dependent effect,2722438,[],CHEMBL1063609,Cytotoxicity against human red blood cells assessed as hemolysis after 30 mins,A,,,BAO_0000375,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1153598,Bioorg Med Chem Lett,2009.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,,829607,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
10640,,,5132236,[],CHEMBL1647921,Antibacterial activity against Bacillus subtilis NBRC 3513 after overnight incubation by medium dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1641423,Bioorg Med Chem Lett,2011.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1318982,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,6.25
10641,,,5132243,[],CHEMBL1647922,Antibacterial activity against Bacillus megaterium ATCC 19213 after overnight incubation by medium dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1641423,Bioorg Med Chem Lett,2011.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1318982,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,6.25
10642,,,5132250,[],CHEMBL1647923,Antibacterial activity against Staphylococcus epidermidis NBRC 12993 after overnight incubation by medium dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1641423,Bioorg Med Chem Lett,2011.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1318982,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,12.5
10643,,,5132257,[],CHEMBL1647924,Antibacterial activity against Staphylococcus aureus NBRC 12732 after overnight incubation by medium dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1641423,Bioorg Med Chem Lett,2011.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1318982,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
10644,,,5132264,[],CHEMBL1647925,Antibacterial activity against Pseudomonas aeruginosa NBRC 3080 after overnight incubation by medium dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1641423,Bioorg Med Chem Lett,2011.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1318982,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,100.0
10645,,,5133337,[],CHEMBL1647926,Antibacterial activity against Escherichia coli NBRC l2734 after overnight incubation by medium dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1641423,Bioorg Med Chem Lett,2011.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1318982,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
10646,,Toxic,5133344,[],CHEMBL1647927,Cytotoxicity against human RBC assessed induction of hemolysis at 100 uL after 30 mins microtiter plate reader analysis,A,,,BAO_0000375,BAO_0000219,cell-based format,CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC1=O,,,CHEMBL1641423,Bioorg Med Chem Lett,2011.0,,CHEMBL556327,GRATISIN,CHEMBL556327,,0,,1318982,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
10647,,,104221,[],CHEMBL658170,Inhibition of DNA gyrase supercoiling in Escherichia coli.,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1130981,Bioorg Med Chem Lett,1998.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,131,=,1,1,=,,IC50,ug.mL-1,,52.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,52.0
10648,,,336591,[],CHEMBL677914,Compound was tested for inhibition of the gram-negative organism Escherichia cloacae HA 2646,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,6.3
10649,,,336592,[],CHEMBL676843,Compound was tested for inhibition of the gram-negative organism Escherichia coli vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,3.1
10650,,,336593,[],CHEMBL676842,Compound was tested for inhibition of the gram-negative organism Escherichia coli H560,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.3
10651,,,336594,[],CHEMBL700551,Compound was tested for inhibition of the gram-negative organism Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,6.3
10652,,,336595,[],CHEMBL767622,Compound was tested for inhibition of the gram-negative organism Providencia rettgeri H1771,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,6.3
10653,,,336596,[],CHEMBL764329,Compound was tested for inhibition of the gram-negative organism Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,100.0
10654,,,336597,[],CHEMBL813313,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus H228.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
10655,,,336598,[],CHEMBL813314,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus UC-76.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
10656,,,336599,[],CHEMBL808164,Compound was tested for inhibition of the gram-negative organism Streptococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,100.0
10657,,,336600,[],CHEMBL810959,Compound was tested for inhibition of the gram-negative organism Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,100.0
10658,,,336601,[],CHEMBL810790,Compound was tested for inhibition of the gram-negative organism Streptococcus pyogenes C203.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,100.0
10659,,,336602,[],CHEMBL742297,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following peroral administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,268925,=,1,0,=,,PD50,mg kg-1,,45.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,45.0
10660,,,336603,[],CHEMBL742298,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following sc administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,268925,=,1,0,=,,PD50,mg kg-1,,26.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,26.0
10661,,,336604,[],CHEMBL742299,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following po administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,268925,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
10662,,,336605,[],CHEMBL742301,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following sc administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,268925,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
10663,,,336606,[],CHEMBL742303,Compound was evaluated for protective dose against the Streptococcus pneumoniae SV-1 lethal infection following po administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,268925,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
10664,,,336607,[],CHEMBL878067,Compound was evaluated for protective dose against Streptococcus pneumoniae SV-1 lethal infection following sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,268925,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
10665,,,336608,[],CHEMBL686749,Inhibition of DNA gyrase of Escherichia coli H560 cells,B,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268925,=,1,0,=,,Min concentration,ug ml-1,,50.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Min concentration,ug ml-1,UO_0000274,,50.0
10666,,,383318,[],CHEMBL670696,In vitro antibacterial activity was measured against nalidixic acid resistant strain 1 from Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348996,>,1,1,>,,MIC,ug.mL-1,,1600.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1600.0
10667,,,383319,[],CHEMBL674435,In vitro antibacterial activity was measured against nalidixic acid resistant strain 2 from Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348996,>,1,1,>,,MIC,ug.mL-1,,1600.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1600.0
10668,,,383320,[],CHEMBL674436,In vitro antibacterial activity was measured against nalidixic acid resistant strain 3 from Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348996,=,1,1,=,,MIC,ug.mL-1,,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,200.0
10669,,,383321,[],CHEMBL674437,In vitro antibacterial activity was measured against nalidixic acid resistant strain 4 from Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348996,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
10670,,,383322,[],CHEMBL674438,In vitro antibacterial activity was measured against nalidixic acid resistant strain 5 from Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348996,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
10671,,,383323,[],CHEMBL674439,In vitro antibacterial activity was measured against nalidixic acid resistant strain 6 from Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348996,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
10672,,,383324,[],CHEMBL674440,In vitro antibacterial activity was measured against nalidixic acid resistant strain 7 from Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348996,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
10673,,,522423,[],CHEMBL806095,In vitro minimum inhibitory concentration against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1121743,J Med Chem,1981.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36395,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,62.5
10674,,,522424,[],CHEMBL806958,Minimum inhibitory dilution of medicated rat urine tested in vitro for antibacterial activity against Staphylococcus aureus; Equal to 1:16,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1121743,J Med Chem,1981.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,36395,=,1,0,=,,MID,,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MID,,,,0.0625
10675,,,522425,[],CHEMBL768996,In vitro minimum inhibitory concentration against Proteus mirabilis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1121743,J Med Chem,1981.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,36395,=,1,1,=,,MIC,ug.mL-1,,15.6,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,15.6
10676,,,522426,[],CHEMBL769006,Minimum inhibitory dilution of medicated rat urine tested in vitro for antibacterial activity against Proteus mirabilis; Equal to 1:128,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1121743,J Med Chem,1981.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,36395,=,1,0,=,,MID,,,0.00781,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MID,,,,0.00781
10677,,,776476,[],CHEMBL686743,Inhibition of supercoiling activity of DNA gyrase in Escherichia coli,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1130179,J Med Chem,1997.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,210406,=,1,1,=,,IC50,ug.mL-1,,52.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,IC50,ug ml-1,UO_0000274,,52.0
10678,,,776477,[],CHEMBL689079,Inhibition of cleavable complex ability of DNA gyrase in Escherichia coli,B,,,BAO_0000187,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1130179,J Med Chem,1997.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,210406,=,1,1,=,,CC50,ug.mL-1,,41.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,CC50,ug ml-1,UO_0000274,,41.0
10679,,,776478,[],CHEMBL675263,Minimum inhibitory concentration of compound against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1130179,J Med Chem,1997.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,210406,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10680,,,776479,[],CHEMBL675265,Minimum inhibitory concentration of compound against KL-16 Escherichia coli strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1130179,J Med Chem,1997.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,210406,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10681,,,776480,[],CHEMBL806036,Minimum inhibitory concentration of compound against OC2603 Staphylococcus epidermidis strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1130179,J Med Chem,1997.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,210406,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,250.0
10682,,,776481,[],CHEMBL810156,Minimum inhibitory concentration of compound against OC6538 Staphylococcus aureus strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1130179,J Med Chem,1997.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,210406,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,500.0
10683,,,894690,[],CHEMBL814303,"In vitro antibacterial activity against Gram-positive, Staphylococcus aureus 209 P",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1121603,J Med Chem,1980.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41518,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
10684,,,894691,[],CHEMBL675523,In vitro for antibacterial activity against Gram-negative Escherichia coli NIJH JC-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1121603,J Med Chem,1980.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41518,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,3.13
10685,,,894692,[],CHEMBL768331,In vitro antibacterial activity against Gram-negative Pseudomonas aeruginosa V-1.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1121603,J Med Chem,1980.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41518,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,100.0
10686,,,907491,[],CHEMBL682926,Minimum inhibitory concentration against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136372,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,69979,=,1,1,=,,MIC,nM,,3000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,3.0
10687,,,907492,[],CHEMBL814219,Minimum inhibitory concentration (MIC) against Staphylococcus aureus ATCC 13709,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136372,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,69979,=,1,1,=,,MIC,nM,,75000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,75.0
10688,,,997067,[],CHEMBL657330,In vitro inhibitory concentration which show total effect against Escherichia coli HR DNA gyrase,B,,,BAO_0000179,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310184,=,1,0,=,,IC0,ug ml-1,,25.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC0,ug ml-1,UO_0000274,,25.0
10689,,,997068,[],CHEMBL657332,In vitro inhibitory concentration which show total effect against Escherichia coli HR DNA gyrase,B,,,BAO_0000179,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310184,=,1,0,=,,IC100,ug ml-1,,200.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC100,ug ml-1,UO_0000274,,200.0
10690,,,997069,[],CHEMBL857618,In vitro antibacterial activity expressed as MIC against Escherichia coli HR DNA gyrase,B,,,BAO_0002146,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1149932,Bioorg Med Chem Lett,1992.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,310184,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,MIC,ug ml-1,UO_0000274,,2.5
10691,,Not Determined,1129668,[],CHEMBL675612,Compound was tested for photoinhibition of Escherichia coli (CIP 548T); No data,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1130650,Bioorg Med Chem Lett,1998.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,190625,,1,0,,,Antibiotic resistance,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Antibiotic resistance,,,,
10692,,Resistant,1129669,[],CHEMBL810268,Compound was tested for photoinhibition of Staphylococcus aureus(CIP 53156); Resistant,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1130650,Bioorg Med Chem Lett,1998.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,190625,,1,0,,,Antibiotic resistance,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Antibiotic resistance,,,,
10693,,,1165309,[],CHEMBL807340,Antibacterial activity against Staphylococcus aureus 209PJC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122582,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,190574,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
10694,,,1165310,[],CHEMBL675392,Antibacterial activity against Escherichia coli NIHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122582,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,190574,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.56
10695,,,1165311,[],CHEMBL771950,Antibacterial activity against Pseudomonas aeruginosa Tsuchijima,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122582,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,190574,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,50.0
10696,,,1165312,[],CHEMBL814103,Median effective dose against Staphylococcus aureus 50774 causing systemic infections,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122582,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,190574,>,1,1,>,,ED50,mg.kg-1,,800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,800.0
10697,,,1165313,[],CHEMBL679259,Median effective dose against Escherichia coli P-5101 causing systemic infections. ,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122582,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,190574,=,1,1,=,,ED50,mg.kg-1,,29.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,29.2
10698,,,1165314,[],CHEMBL878684,Median effective dose against Pseudomonas aeruginosa 12 causing systemic infections,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122582,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,190574,=,1,1,=,,ED50,mg.kg-1,,267.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,267.0
10699,,,1165315,[],CHEMBL725201,Compound was tested for acute toxicity test with a single oral administration in mice and the median lethal dose as calculated.,A,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122582,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,190574,=,1,1,=,,LD50,mg.kg-1,,1800.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,1800.0
10700,,,1172773,[],CHEMBL682964,In vitro antibacterial activity was determined against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10701,,,1172774,[],CHEMBL682394,Evaluated for the minimum inhibitory concentration against Escherichia coli TEM-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
10702,,,1172775,[],CHEMBL657703,Evaluated for the minimum inhibitory concentration against Citrobacter freundii BS-16.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,8.0
10703,,,1172776,[],CHEMBL675298,Minimum inhibitory concentration against Enterobacter cloacae P99 (Class Ia beta-lactamase overproducer),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
10704,,,1172777,[],CHEMBL806739,Evaluated for the minimum inhibitory concentration against Serratia marcescens 1071,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,2.0
10705,,,1172778,[],CHEMBL767766,Minimum inhibitory concentration against Proteus vulgaris 1028 BC (Class Ic beta-lactamase overproducer),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,2.0
10706,,,1172779,[],CHEMBL765706,Minimum inhibitory concentration against Proteus mirabilis 90,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,8.0
10707,,,1172780,[],CHEMBL766014,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
10708,,,1172781,[],CHEMBL766013,Evaluated for the minimum inhibitory concentration against Pseudomonas aeruginosa 18S/H (Class Id beta-lactamase overproducer),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
10709,,,1172782,[],CHEMBL809035,"Minimum inhibitory concentration against Staphylococcus aureus ATCC 29213 (inducible, low level beta-lactamase producer)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10710,,,1172783,[],CHEMBL809033,"Minimum inhibitory concentration against Staphylococcus aureus 1059B (inducible, high level beta-lactamase producer)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
10711,,,1172784,[],CHEMBL880937,"Minimum inhibitory concentration against Staphylococcus aureus 95 (Methicillin-resistant, high-level beta-lactamase producer)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
10712,,,1172785,[],CHEMBL812920,Minimum inhibitory concentration against Streptococcus pneumoniae 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
10713,,,1172786,[],CHEMBL816704,Minimum inhibitory concentration against Streptococcus pyogenes 4,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,128.0
10714,,,1172787,[],CHEMBL676024,Evaluated for the minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1125107,J Med Chem,1990.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,334074,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,128.0
10715,,,1176036,[],CHEMBL687258,In vitro antibacterial activity was determined as inhibitory concentration causing 50% DNA-gyrase supercoiling inhibition (SCI),B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,IC50,ug.mL-1,,52.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,52.0
10716,,,1176037,[],CHEMBL687375,Concentration facilitating 50% of the maximum of the cleavable complex,B,,,BAO_0000187,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,CC50,ug.mL-1,,41.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,CC50,ug ml-1,UO_0000274,,41.0
10717,,,1176038,[],CHEMBL682907,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
10718,,,1176039,[],CHEMBL682908,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
10719,,,1176040,[],CHEMBL800634,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,3.9,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,3.9
10720,,,1176041,[],CHEMBL800635,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
10721,,,1176042,[],CHEMBL771164,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,62.5
10722,,,1176043,[],CHEMBL771165,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,15.6,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,15.6
10723,,,1176044,[],CHEMBL678554,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10724,,,1176045,[],CHEMBL678555,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
10725,,,1176046,[],CHEMBL807179,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus epidermidis strain OC2603,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,250.0
10726,,,1176047,[],CHEMBL808643,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus aureus strain OC6538,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1127182,Bioorg Med Chem Lett,1993.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,132879,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,500.0
10727,,,1177454,[],CHEMBL679918,Activity against Enterobacter aerogenes,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,166636,=,1,0,=,,CMI,mg l-1,,3.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,CMI,mg l-1,,,3.0
10728,,,1177455,[],CHEMBL876624,Bioavailability,A,,,BAO_0003042,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,166636,=,1,1,=,,F,%,,60.0,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,60.0
10729,,Active,1177456,[],CHEMBL679065,The compound has antimicrobial activity against Enterococcus faecalis; Active,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,166636,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
10730,,Active,1177457,[],CHEMBL809615,The compound has antimicrobial activity against Staphylococcus aureus; Active,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,166636,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
10731,,Active,1177458,[],CHEMBL765160,The compound has antimicrobial activity against Proteus mirabilis; Active,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,166636,,1,0,,,Activity,,,,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,,,,
10732,,Not Active,1177459,[],CHEMBL877706,Antimicrobial activity against Escherichia coli;IA is Inactive,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,166636,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10733,,Not Active,1177460,[],CHEMBL764783,Antimicrobial activity against Pseudomonas aeruginosa 108;IA is Inactive,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,166636,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
10734,,,1252497,[],CHEMBL857198,MIC at which cleaved DNA (linear) is observed at an intensity relative to oxolinic acid at 10 ug/mL by using Gyrase Induced DNA-Cleavage assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
10735,,,1252498,[],CHEMBL688001,Inhibitory concentration in supercoiling inhibition Escherichia coli DNA gyrase assay,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,>,1,1,>,,IC50,ug.mL-1,,100.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,I50,ug ml-1,UO_0000274,,100.0
10736,,,1252499,[],CHEMBL675494,Antibacterial activity against Escherichia coli (H560),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,6.3
10737,,,1252500,[],CHEMBL675496,Antibacterial activity against Escherichia coli (vogel),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,6.3
10738,,,1252501,[],CHEMBL705833,Antibacterial activity against Klebsiella pneumonia (MGH-2),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,6.3
10739,,,1252502,[],CHEMBL770156,Antibacterial activity against Pseudomonas aeruginosa (UI-18),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,100.0
10740,,,1252503,[],CHEMBL809476,Antibacterial activity against Staphylococcus aureus (H228),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,100.0
10741,,,1252504,[],CHEMBL809331,Antibacterial activity against Streptococcus pneumoniae (SV-1),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249237,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,100.0
10742,,,1270455,[],CHEMBL814306,In vitro antibacterial activity against Staphylococcus aureus (ATCC 13709),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122583,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196530,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
10743,,,1270456,[],CHEMBL679384,In vitro antibacterial activity against Escherichia coli (ATCC 9637),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122583,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196530,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.5
10744,,,1270457,[],CHEMBL801474,In vitro antibacterial activity against Salmonella gallinarum (ATCC 9184),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122583,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196530,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL612604,Salmonella enterica subsp. enterica serovar Gallinarum,Salmonella enterica subsp. enterica serovar Gallinarum,594.0,,,MIC,ug ml-1,UO_0000274,,12.5
10745,,,1270458,[],CHEMBL700096,In vitro antibacterial activity against Klebsiella pneumoniae AD (ATCC 10031),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122583,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196530,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,3.13
10746,,,1270459,[],CHEMBL752181,In vitro antibacterial activity against Mycobacterium smegmatis (ATCC 607),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122583,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196530,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,100.0
10747,,,1270460,[],CHEMBL651324,In vitro antibacterial activity against Candida albicans (ATCC 10231),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122583,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196530,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,100.0
10748,,,1270461,[],CHEMBL660637,In vitro DNA gyrase inhibition activity,B,,,BAO_0002752,BAO_0000225,nucleic acid format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1122583,J Med Chem,1984.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196530,=,1,0,=,,Concentration,ug ml-1,,40.0,CHEMBL345,,Nucleic Acid,,,,Concentration,ug ml-1,UO_0000274,,40.0
10749,,,1436857,[],CHEMBL826190,Percent inhibition of filarial parasite Setaria cervi by compound at 40 ug/mL concentration,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145230,Bioorg Med Chem Lett,2005.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,371006,=,1,1,=,,Inhibition,%,,80.0,CHEMBL612545,,Unchecked,,,,Inhibition,%,UO_0000187,,80.0
10750,,,1436858,[],CHEMBL826189,Percent inhibition of filarial parasite Setaria cervi by compound at 20 ug/mL concentration,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145230,Bioorg Med Chem Lett,2005.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,371006,=,1,1,=,,Inhibition,%,,40.0,CHEMBL612545,,Unchecked,,,,Inhibition,%,UO_0000187,,40.0
10751,,,1436859,[],CHEMBL826188,Percent inhibition of filarial parasite Setaria cervi by compound at 10 ug/mL concentration,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145230,Bioorg Med Chem Lett,2005.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,371006,=,1,1,=,,Inhibition,%,,20.0,CHEMBL612545,,Unchecked,,,,Inhibition,%,UO_0000187,,20.0
10752,,Not Active,1436860,[],CHEMBL877436,Percent inhibition of filarial parasite Setaria cervi by compound at 5 ug/mL concentration; NI = no inhibition,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145230,Bioorg Med Chem Lett,2005.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,371006,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,Inhibition,%,UO_0000187,,
10753,,,1684021,[],CHEMBL862064,Inhibition of Bacillus subtilis topoisomerase4 activity,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428203,=,1,1,=,,IC50,ug.mL-1,,34.6,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,34.6
10754,,,1684027,[],CHEMBL862002,Inhibition of Bacillus subtilis gyrase activity,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1138117,J Med Chem,2006.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428203,=,1,1,=,,IC50,ug.mL-1,,276.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,276.0
10755,,,1826972,[],CHEMBL909713,Bacteriostatic activity against Escherichia coli DM4100 in aerobic condition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625565,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.0
10756,,,1826973,[],CHEMBL910810,Bacteriostatic activity against Escherichia coli DM4100 in anaerobic condition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625565,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.0
10757,,Not Active,1826975,[],CHEMBL910812,Bactericidal activity against Escherichia coli DM4100 in saline,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,625565,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10758,,Not Active,1826976,[],CHEMBL910813,Bactericidal activity against Escherichia coli DM4100 in anaerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,625565,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10759,,Not Active,1826977,[],CHEMBL910814,Bactericidal activity against Escherichia coli DM4100 in the presence of chloramphenicol,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,625565,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10760,,,1827243,[],CHEMBL855936,Inhibition of Bacillus subtilis topoisomerase 4,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142158,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,625704,=,1,1,=,,IC50,nM,,1090000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1090.0
10761,,,1827247,[],CHEMBL855937,Inhibition of Bacillus subtilis gyrase,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142158,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,625704,=,1,1,=,,IC50,nM,,149000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,149.0
10762,,,1829252,[],CHEMBL912048,Inhibitory activity against azide-resistant Escherichia coli J53,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10763,,,1829253,[],CHEMBL912049,Inhibitory activity against Escherichia coli 12-1502,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
10764,,,1829254,[],CHEMBL912050,Inhibitory activity against Klebsiella pneumoniae 12-1183,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10765,,,1829255,[],CHEMBL912051,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1183,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
10766,,,1829259,[],CHEMBL912052,Inhibitory activity against Klebsiella pneumoniae 35,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10767,,,1829260,[],CHEMBL912053,Inhibitory activity against azide-resistant Escherichia coli J53 T35,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
10768,,,1829262,[],CHEMBL912054,Inhibitory activity against Klebsiella pneumoniae 07-006,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10769,,,1829265,[],CHEMBL912055,Inhibitory activity against azide-resistant Escherichia coli J53 T07-006,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
10770,,,1829266,[],CHEMBL912056,Inhibitory activity against Klebsiella pneumoniae 03-222,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
10771,,,1829267,[],CHEMBL912057,Inhibitory activity against azide-resistant Escherichia coli J53 T03-222,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
10772,,,1829268,[],CHEMBL912058,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1502,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625669,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
10773,,Active,1832966,[],CHEMBL910811,Bactericidal activity against Escherichia coli DM4100 in aerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,625565,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10774,,Active,1832970,[],CHEMBL910821,Chromosome fragmentation in Escherichia coli DM4100 assessed as reduced lysate viscosity at 50 ug/ml after 2 hrs in aerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,625565,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10775,,,1834050,[],CHEMBL855355,Antibacterial activity against Streptococcus suis ATCC 43765 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10776,,,1834054,[],CHEMBL855356,Antibacterial activity against Streptococcus suis BB1001 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10777,,,1834058,[],CHEMBL855357,Antibacterial activity against Streptococcus suis BB1002 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10778,,,1834062,[],CHEMBL855358,Antibacterial activity against Streptococcus suis BB1003 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10779,,,1834066,[],CHEMBL855359,Antibacterial activity against Streptococcus suis BB1004 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10780,,,1834070,[],CHEMBL855360,Antibacterial activity against Streptococcus suis BB1005 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10781,,,1834074,[],CHEMBL855361,Antibacterial activity against Streptococcus suis BB1006 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10782,,,1834078,[],CHEMBL855362,Antibacterial activity against Streptococcus suis BB1007 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10783,,,1834082,[],CHEMBL855363,Antibacterial activity against Streptococcus suis BB1008 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10784,,,1834086,[],CHEMBL855364,Antibacterial activity against Streptococcus suis BB1009 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10785,,,1834090,[],CHEMBL855365,Antibacterial activity against Streptococcus suis BB1010 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10786,,,1834094,[],CHEMBL855366,Antibacterial activity against Streptococcus suis BB1011 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10787,,,1834098,[],CHEMBL855367,Antibacterial activity against Streptococcus suis BB1012 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10788,,,1834102,[],CHEMBL855368,Antibacterial activity against Streptococcus suis BB1013 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10789,,,1834106,[],CHEMBL855369,Antibacterial activity against Streptococcus suis BB1014 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10790,,,1834110,[],CHEMBL855370,Antibacterial activity against Streptococcus suis BB1015 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10791,,,1834114,[],CHEMBL855371,Antibacterial activity against Streptococcus suis BB1016 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10792,,,1834118,[],CHEMBL854309,Antibacterial activity against Streptococcus suis BB1017 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625840,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
10793,,,1834387,[],CHEMBL855385,Antimicrobial activity against Salmonella enterica serovar Typhimurium SMP972 in Caenorhabditis elegans,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142199,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625960,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,64.0
10794,,,1834388,[],CHEMBL855384,Antimicrobial activity against Salmonella enterica serovar Typhimurium SMP973 in Caenorhabditis elegans,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142199,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625960,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10795,,,1835643,[],CHEMBL854042,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
10796,,,1835758,[],CHEMBL854043,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 gyrA+,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
10797,,,1835759,[],CHEMBL854044,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 acrAB::Kan,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
10798,,,1835760,[],CHEMBL854045,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 tolC::Kan,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
10799,,,1835761,[],CHEMBL854046,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 GyrA S83F mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10800,,,1835762,[],CHEMBL854047,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 gyrA+,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
10801,,,1835763,[],CHEMBL854048,Antimicrobial activity against Salmonella enterica serovar Typhimurium GyrA S21-1 acrAB::Kan with GyrA S83F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
10802,,,1835764,[],CHEMBL854049,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 tolC::Kan with GyrA S83F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
10803,,,1835765,[],CHEMBL854050,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10804,,,1835766,[],CHEMBL854051,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,64.0
10805,,,1835767,[],CHEMBL854052,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,64.0
10806,,,1835768,[],CHEMBL854053,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,64.0
10807,,,1835769,[],CHEMBL854054,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10808,,,1835770,[],CHEMBL854140,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10809,,,1835771,[],CHEMBL854141,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,64.0
10810,,,1835772,[],CHEMBL855232,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
10811,,,1835773,[],CHEMBL855233,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10812,,,1835774,[],CHEMBL855234,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10813,,,1835775,[],CHEMBL855231,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10814,,,1835776,[],CHEMBL855786,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10815,,,1835777,[],CHEMBL855787,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10816,,,1835778,[],CHEMBL855788,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
10817,,,1835779,[],CHEMBL855789,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10818,,,1835780,[],CHEMBL855790,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10819,,,1835781,[],CHEMBL855791,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10820,,,1835782,[],CHEMBL855792,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
10821,,,1835783,[],CHEMBL855793,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10822,,,1835784,[],CHEMBL855794,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 tolC::Kan with GyrA S83F, D87N, parC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10823,,,1835785,[],CHEMBL855795,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10824,,,1835786,[],CHEMBL855796,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
10825,,,1835787,[],CHEMBL855797,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10826,,,1835788,[],CHEMBL855798,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10827,,,1835789,[],CHEMBL855799,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,128.0
10828,,,1835790,[],CHEMBL854744,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 gyrA+ with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
10829,,,1835791,[],CHEMBL854745,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 acrAB::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
10830,,,1835792,[],CHEMBL854746,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 tolC::Kan with GyrA D87G mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,16.0
10831,,,1835793,[],CHEMBL854747,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,256.0
10832,,,1835794,[],CHEMBL854748,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 gyrA+ with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
10833,,,1835795,[],CHEMBL854749,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 acrAB::Kan with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,16.0
10834,,,1835796,[],CHEMBL854750,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 tolC::Kan with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
10835,,,1835797,[],CHEMBL855813,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
10836,,,1835798,[],CHEMBL855814,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 gyrA+ with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
10837,,,1835799,[],CHEMBL855815,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 acrAB::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
10838,,,1835800,[],CHEMBL855816,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 tolC::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625580,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
10839,,,1850153,[],CHEMBL920752,Antimicrobial susceptibility against Haemophilus influenzae A isolate with GyrA Glu83Cys and AcrR 97stop codon mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
10840,,,1850156,[],CHEMBL920753,"Antimicrobial susceptibility against Haemophilus influenzae A1 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.0
10841,,,1850159,[],CHEMBL920754,"Antimicrobial susceptibility against Haemophilus influenzae A2 with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,64.0
10842,,,1850162,[],CHEMBL920755,"Antimicrobial susceptibility against Haemophilus influenzae A3 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,64.0
10843,,,1850165,[],CHEMBL920756,"Antimicrobial susceptibility against Haemophilus influenzae A4 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,128.0
10844,,,1850168,[],CHEMBL920196,Antimicrobial susceptibility against Haemophilus influenzae B isolate with AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
10845,,,1850171,[],CHEMBL920197,Antimicrobial susceptibility against Haemophilus influenzae B1 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,32.0
10846,,,1850174,[],CHEMBL920198,Antimicrobial susceptibility against Haemophilus influenzae B2 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,64.0
10847,,,1850177,[],CHEMBL920199,Antimicrobial susceptibility against Haemophilus influenzae C isolate with AcrR Leu31His and Arg34Glu mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
10848,,,1850180,[],CHEMBL920200,"Antimicrobial susceptibility against Haemophilus influenzae C1 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,16.0
10849,,,1850183,[],CHEMBL920201,"Antimicrobial susceptibility against Haemophilus influenzae C2 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,128.0
10850,,,1850186,[],CHEMBL920202,"Antimicrobial susceptibility against Haemophilus influenzae C3 isolate with GyrA Asp88Asn, ParC Ser84Ile, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,128.0
10851,,,1850189,[],CHEMBL920203,"Antimicrobial susceptibility against Haemophilus influenzae D isolate with AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
10852,,,1850192,[],CHEMBL920204,"Antimicrobial susceptibility against Haemophilus influenzae D1 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,64.0
10853,,,1850195,[],CHEMBL920205,"Antimicrobial susceptibility against Haemophilus influenzae D2 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,64.0
10854,,,1850198,[],CHEMBL920206,"Antimicrobial susceptibility against Haemophilus influenzae D3 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,128.0
10855,,,1850201,[],CHEMBL920207,"Antimicrobial susceptibility against Haemophilus influenzae D4 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634943,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,128.0
10856,,,1866125,[],CHEMBL916027,Susceptibility of qnr positive Enterobacter cloacae,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634788,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
10857,,,1866127,[],CHEMBL916027,Susceptibility of qnr positive Enterobacter cloacae,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634788,>,1,1,>,,MIC90,ug.mL-1,,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,256.0
10858,,,1866131,[],CHEMBL916555,Antimicrobial activity against Escherichia coli qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634767,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
10859,,,1866132,[],CHEMBL916556,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 transconjugant with qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634767,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
10860,,,1866133,[],CHEMBL916557,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634767,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
10861,,,1866766,[],CHEMBL916028,Susceptibility of qnr positive Enterobacter cloacae assessed as percentage nonsusceptible isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,634788,=,1,0,=,,Activity,%,,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,100.0
10862,,,1866781,[],CHEMBL916031,Decrease in susceptibility of qnrS-positive transconjugant streptomycin-resistant Escherichia coli C600,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634788,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
10863,,,1866791,[],CHEMBL916032,Decrease in susceptibility of qnrB-positive transconjugant streptomycin-resistant Escherichia coli C600,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1147091,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634788,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
10864,,,1867049,[],CHEMBL904486,Antimicrobial activity against Escherichia coli AG100 mutant with argE3 thi-3 rpsL xyl mtl supE44 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.0
10865,,Not Determined,1867054,[],CHEMBL904487,Antimicrobial activity against Escherichia coli M013 mutant with AG100 delta-(lon-hupB-ppiD) dupIS5 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,634722,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
10866,,,1867066,[],CHEMBL904488,Antimicrobial activity against Escherichia coli M043 mutant with AG100 lon4::IS186 marR::IS2 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10867,,,1867071,[],CHEMBL904489,Antimicrobial activity against Escherichia coli M044 mutant with AG100 lon4::IS186 marR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.0
10868,,,1867083,[],CHEMBL904490,Antimicrobial activity against Escherichia coli M064 mutant with AG100 lon1::IS186 acrR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.0
10869,,,1867088,[],CHEMBL904491,Antimicrobial activity against Escherichia coli M073 mutant with AG100 lon2::IS186 acrR::IS5 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10870,,,1867093,[],CHEMBL904492,Antimicrobial activity against Escherichia coli M074 mutant with AG100 lon2::IS186 acrR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10871,,,1867105,[],CHEMBL904493,Antimicrobial activity against Escherichia coli M083 mutant with AG100 lon4::IS186 acrR::IS1 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10872,,,1867110,[],CHEMBL904494,Antimicrobial activity against Escherichia coli M084 mutant AG100 lon4::IS186 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.0
10873,,,1867122,[],CHEMBL904495,Antimicrobial activity against Escherichia coli M093 mutant with AG100 lon3::IS186 acrR::IS1 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10874,,,1867127,[],CHEMBL904496,Antimicrobial activity against Escherichia coli M103 mutant with AG100 lon3::IS186 acrR-acrAB genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.0
10875,,,1867132,[],CHEMBL904497,Antimicrobial activity against Escherichia coli M104 mutant with AG100 dupIS3 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10876,,,1867144,[],CHEMBL904498,Antimicrobial activity against Escherichia coli M114 mutant with AG100 lon4::IS186 marR::IS2 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10877,,,1867149,[],CHEMBL904499,Antimicrobial activity against Escherichia coli M124 mutant with AG100 lon4::IS186 acrR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10878,,,1867172,[],CHEMBL904500,Antimicrobial activity against Escherichia coli AG112 mutant with AG100 marR genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.0
10879,,,1867176,[],CHEMBL904501,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 250 generations in 5 ug/ml presence of tetracycline,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,192.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,192.0
10880,,,1867180,[],CHEMBL904502,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 125 generations in absence of tetracycline,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634722,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,24.0
10881,,,2124457,[],CHEMBL953034,Inhibition of Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as inhibition of pBR322 DNA supercoiling,B,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704418,=,1,1,=,,IC50,ug.mL-1,,300.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,300.0
10882,,Not Active,2124470,[],CHEMBL953035,Effect on Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as enhancement of supercoiled pBR322 DNA cleavage,B,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,704418,,1,0,,,Activity,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,,,,
10883,,Not Determined,2124483,[],CHEMBL953036,Antibacterial activity against Mycobacterium leprae at 5 ug/mL after 11 to 18 days,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,704418,,1,0,,,Activity,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,,,,
10884,,Not Determined,2124507,[],CHEMBL938433,Antibacterial activity in Mycobacterium leprae infected mouse foot-pad model assessed as parasite killing after 9 months,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,704418,,1,0,,,Activity,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,,,,
10885,,,2139362,[],CHEMBL927048,Antimicrobial activity against Escherichia coli at 50 ug/disk after 24 to 28 hrs,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143876,Bioorg Med Chem,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,701686,=,1,1,=,,IZ,mm,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,24.0
10886,,,2139372,[],CHEMBL927049,Antimicrobial activity against Klebsiella pneumoniae at 50 ug/disk after 24 to 28 hrs,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143876,Bioorg Med Chem,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,701686,=,1,1,=,,IZ,mm,,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,25.0
10887,,,2139382,[],CHEMBL927050,Antimicrobial activity against Pseudomonas aeruginosa at 50 ug/disk after 24 to 28 hrs,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143876,Bioorg Med Chem,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,701686,=,1,1,=,,IZ,mm,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,25.0
10888,,,2139392,[],CHEMBL927051,Antimicrobial activity against Staphylococcus aureus at 50 ug/disk after 24 to 28 hrs,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143876,Bioorg Med Chem,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,701686,=,1,1,=,,IZ,mm,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,25.0
10889,,,2168653,[],CHEMBL934825,Inhibition of transcription-translation activity in Escherichia coli,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1145648,Bioorg Med Chem Lett,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,711981,>,1,1,>,,IC50,nM,,100000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,uM,UO_0000065,,100.0
10890,,Not Active,2316908,[],CHEMBL987566,Inhibition of tubulin polymerization in rat C6 cells at 50 ug/mL to 2.5 mg/mL after 4 hrs,B,,,BAO_0000375,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1158219,J Nat Prod,1996.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,788708,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
10891,,Not Active,2316923,[],CHEMBL988383,Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP,F,,,BAO_0000375,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1158219,J Nat Prod,1996.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,788708,,1,0,,,Activity,,,,CHEMBL614657,Rattus norvegicus,C6,10116.0,,,Activity,,,,
10892,,Not Active,2316942,[],CHEMBL987562,Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL after 3 days treated 4 hrs before db-cAMP challenge by MTT assay,F,,,BAO_0000375,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1158219,J Nat Prod,1996.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,788708,,1,0,,,Activity,,,,CHEMBL614657,Rattus norvegicus,C6,10116.0,,,Activity,,,,
10893,,,2344493,[],CHEMBL966139,Antimicrobial activity against Citrobacter freundii 33587 isolate by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150790,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794330,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,2.0
10894,,,2344506,[],CHEMBL966141,Antimicrobial activity against Escherichia coli 33587-TC9 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150790,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794330,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
10895,,,2344519,[],CHEMBL966140,Antimicrobial activity against Escherichia coli CAG12177 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150790,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794330,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
10896,,,2345522,[],CHEMBL955639,Antimicrobial activity against Vibrio splendidus 12B01 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,,MIC,ug ml-1,UO_0000274,,2.0
10897,,,2345523,[],CHEMBL955640,Antimicrobial activity against Vibrio splendidus LGP32 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,,MIC,ug ml-1,UO_0000274,,4.0
10898,,,2345524,[],CHEMBL956419,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS1 expressing quinolone resistant Vibrio splendidus 12B01 QnrVS1 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10899,,,2345525,[],CHEMBL956420,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS2 expressing quinolone resistant Vibrio splendidus LGP32 QnrVS2 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10900,,,2345526,[],CHEMBL956421,Antimicrobial activity against Escherichia coli TOP10 harbouring pS1 plasmid expressing quinolone resistant QnrS1 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10901,,,2345527,[],CHEMBL956422,Antimicrobial activity against Escherichia coli TOP10 harbouring pS2 plasmid expressing quinolone resistant QnrS2 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10902,,,2345528,[],CHEMBL956423,Antimicrobial activity against Escherichia coli TOP10 harbouring p0 plasmid expressing pCR-BluntII-TOPO,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10903,,,2345529,[],CHEMBL956424,Antimicrobial activity against Escherichia coli TOP10,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793427,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10904,,,2347409,[],CHEMBL957902,Antibacterial activity against Escherichia coli C600Rif by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10905,,,2347416,[],CHEMBL957904,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
10906,,,2347423,[],CHEMBL957905,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
10907,,,2347430,[],CHEMBL957906,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10908,,,2347437,[],CHEMBL957907,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
10909,,,2347444,[],CHEMBL957908,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
10910,,,2347451,[],CHEMBL957909,Antibacterial activity against Escherichia coli TOP10 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
10911,,,2347458,[],CHEMBL957910,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10912,,,2347465,[],CHEMBL957911,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10913,,,2347472,[],CHEMBL957912,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
10914,,,2347479,[],CHEMBL957913,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10915,,,2347486,[],CHEMBL957914,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10916,,,2347493,[],CHEMBL957915,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
10917,,,2347500,[],CHEMBL957916,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10918,,,2347507,[],CHEMBL957917,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793432,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10919,,,2348481,[],CHEMBL960520,Antibacterial activity against Enterobacter cloacae S1 isolate expressing quinolone resistance determinant QnrB4 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792942,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,256.0
10920,,,2348482,[],CHEMBL960519,Antibacterial activity against Escherichia coli TOP10 containing pS1A plasmid expressing quinolone resistance determinant QnrB4 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792942,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10921,,,2348483,[],CHEMBL960518,Antibacterial activity against Escherichia coli TOP10 containing pS1B plasmid expressing quinolone resistance determinant QnrS1 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792942,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
10922,,,2348484,[],CHEMBL960517,Antibacterial activity against Escherichia coli TOP10 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792942,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10923,,,2351679,[],CHEMBL957198,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/363-5036 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157372,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793026,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,,MIC,ug ml-1,UO_0000274,,1.0
10924,,,2351680,[],CHEMBL957199,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/363-5034 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157372,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793026,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,,MIC,ug ml-1,UO_0000274,,1.0
10925,,,2351681,[],CHEMBL957200,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/422-5063 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157372,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793026,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,,MIC,ug ml-1,UO_0000274,,16.0
10926,,,2351682,[],CHEMBL957201,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/367-5042 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157372,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793026,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,,MIC,ug ml-1,UO_0000274,,16.0
10927,,,2351683,[],CHEMBL957202,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/367-5043 isolate containing gyrA position 83 Ser-Ile substitution mutation from Atlantic cod after 5 days by microplate broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157372,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793026,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,,MIC,ug ml-1,UO_0000274,,8.0
10928,,,2351684,[],CHEMBL957203,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/494-5106 isolate containing parC position 83 Ser-Ile substitution mutation from Atlantic cod after 5 days by microplate broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1157372,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793026,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,,MIC,ug ml-1,UO_0000274,,128.0
10929,,Active,2394996,[],CHEMBL1007151,Inhibition of DNA gyrase assessed as pBR322 DNA relaxation at 2.5 uM,B,,,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1140876,Bioorg Med Chem,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,729737,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
10930,,Active,2394997,[],CHEMBL1007148,Inhibition of DNA gyrase assessed as conversion of relaxed pBR322 to supercoiled form,B,,,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1140876,Bioorg Med Chem,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,729737,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
10931,,Active,2495129,[],CHEMBL1028824,Increase in ompX-lacZ expression in Escherichia coli deltaompX mutant assessed as increase in beta-galactosidase activity after 60 mins relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,779605,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10932,,Active,2495136,[],CHEMBL1028825,Increase in ompX-lacZ expression in Escherichia coli JM109 assessed as ompX upregulation after 60 mins relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,779605,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10933,,Active,2495143,[],CHEMBL1028826,Increase in ompX-lacZ expression in Escherichia coli JM109 assessed as increase in beta-galactosidase activity after 60 mins relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,779605,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
10934,,Active,2495150,[],CHEMBL1028827,Increase in ompX-lacZ expression in Enterobacter aerogenes ATCC 15038 assessed as ompX upregulation after 60 mins relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,779605,,1,0,,,Activity,,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,Activity,,,,
10935,,Active,2495157,[],CHEMBL1028828,Increase in ompX-lacZ expression in Enterobacter aerogenes ATCC 15038 assessed as increase in beta-galactosidase activity after 60 mins relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,779605,,1,0,,,Activity,,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,Activity,,,,
10936,,,2499749,[],CHEMBL992264,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778814,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
10937,,,2499771,[],CHEMBL992265,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778814,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10938,,,2499793,[],CHEMBL992266,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778814,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10939,,,2499815,[],CHEMBL992267,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778814,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10940,,,2499837,[],CHEMBL992268,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778814,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10941,,,2499859,[],CHEMBL992269,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778814,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
10942,,,2499881,[],CHEMBL992270,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,778814,=,1,0,=,,Ratio,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,2.0
10943,,,2500116,[],CHEMBL1016072,Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779506,>,1,1,>,,MIC50,ug.mL-1,,256.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC50,ug ml-1,UO_0000274,,256.0
10944,,,2500117,[],CHEMBL1016073,Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779506,>,1,1,>,,MIC50,ug.mL-1,,256.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC50,ug ml-1,UO_0000274,,256.0
10945,,,2500118,[],CHEMBL1016072,Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779506,>,1,1,>,,MIC90,ug.mL-1,,256.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC90,ug ml-1,UO_0000274,,256.0
10946,,,2500119,[],CHEMBL1016073,Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779506,>,1,1,>,,MIC90,ug.mL-1,,256.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC90,ug ml-1,UO_0000274,,256.0
10947,,,2500120,[],CHEMBL1016074,Antimicrobial activity against Mycoplasma putrefaciens KS1 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779506,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,,MIC,ug ml-1,UO_0000274,,512.0
10948,,,2500224,[],CHEMBL1019527,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,12.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,12.0
10949,,,2500236,[],CHEMBL1019530,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,21.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,21.0
10950,,,2500242,[],CHEMBL1019523,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,24.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,24.0
10951,,,2500247,[],CHEMBL1019524,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,27.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,27.0
10952,,,2500250,[],CHEMBL1019529,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,29.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,29.0
10953,,,2500251,[],CHEMBL1019528,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,30.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,30.0
10954,,,2500257,[],CHEMBL1019525,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,33.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,33.0
10955,,,2500261,[],CHEMBL1019526,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by standard disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,780148,=,1,1,=,,IZ,mm,,40.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,IZ,mm,UO_0000016,,40.0
10956,,,2504245,[],CHEMBL963582,Antitrypanosomal activity against Trypanosoma cruzi DM28 epimastigotes at 200 ug/ml after 96 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1141026,Bioorg Med Chem Lett,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,753270,=,1,0,=,,Activity,%,,60.0,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,5693.0,,,Activity,%,UO_0000187,,60.0
10957,,,2573951,[],CHEMBL990972,Antimicrobial activity against CTX-M extended-spectrum beta-lactamase producing commensal Escherichia coli isolates from healthy children assessed as percent resistant isolates by disc diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1155170,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,742627,=,1,0,=,,Activity,%,,57.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,57.0
10958,,,2573953,[],CHEMBL990973,Antimicrobial activity against CTX-M-15 extended-spectrum beta-lactamase producing commensal Escherichia coli isolates from healthy children assessed as percent resistant isolates by disc diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1155170,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,742627,=,1,0,=,,Activity,%,,93.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,93.0
10959,,Not Active,2591812,[],CHEMBL965578,Inhibition of mouse brain MAOA,B,,,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1152129,J Med Chem,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,725881,,1,0,,,Activity,,,,CHEMBL3681,Mus musculus,Monoamine oxidase A,10090.0,,,Activity,,,,
10960,,,2660457,[],CHEMBL1061285,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 H103 after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
10961,,,2660458,[],CHEMBL1061286,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
10962,,,2660459,[],CHEMBL1061287,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
10963,,,2660460,[],CHEMBL1061288,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
10964,,,2660461,[],CHEMBL1061289,Antibacterial activity against 69_C12 allele containing Pseudomonas aeruginosa PAO1 H1109 mutant strain with recA::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
10965,,,2660462,[],CHEMBL1061290,Antibacterial activity against 6_G1 allele containing Pseudomonas aeruginosa PAO1 H1121 mutant strain with PA4961::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
10966,,,2660463,[],CHEMBL1061291,Antibacterial activity against 53_F11 allele containing Pseudomonas aeruginosa PAO1 H1124 mutant strain with PA5279::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
10967,,,2660464,[],CHEMBL1061292,Antibacterial activity against 16_G12 allele containing Pseudomonas aeruginosa PAO1 H1125 mutant strain with recG::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
10968,,,2660465,[],CHEMBL1061293,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+c mutant strain with lon::lux/lon+ mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
10969,,,2660466,[],CHEMBL1061294,Antibacterial activity against 70_H3 allele containing Pseudomonas aeruginosa PAO1 H1129 mutant strain with rnt::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
10970,,,2660467,[],CHEMBL1061295,Antibacterial activity against 63_H5 allele containing Pseudomonas aeruginosa PAO1 H1133 mutant strain with nfxB::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
10971,,,2660468,[],CHEMBL1061296,Antibacterial activity against 75_F11 allele containing Pseudomonas aeruginosa PAO1 H1136 mutant strain with PA5455::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817424,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
10972,,,2660501,[],CHEMBL1061302,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,817424,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
10973,,,2660502,[],CHEMBL1061303,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,817424,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
10974,,,2660503,[],CHEMBL1061304,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,817424,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
10975,,,2660504,[],CHEMBL1061305,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+ mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,817424,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
10976,,,2663899,[],CHEMBL960874,Antibacterial activity against wild type Salmonella enterica serovar Typhimurium ATCC 14028 by modified twofold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151446,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818794,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,3.0
10977,,,2663900,[],CHEMBL960150,Antibacterial activity against bacterial sensory kinase PhoQ deficient Salmonella enterica serovar Typhimurium CS009 by modified twofold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151446,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818794,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,3.0
10978,,,2663951,[],CHEMBL1023510,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818802,>=,1,1,>=,,MIC,ug.mL-1,,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,256.0
10979,,,2663952,[],CHEMBL1023538,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818802,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,128.0
10980,,,2663953,[],CHEMBL1023539,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818802,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
10981,,,2663954,[],CHEMBL1023540,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818802,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
10982,,,2663955,[],CHEMBL1023541,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818802,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
10983,,,2663956,[],CHEMBL1023542,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818802,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10984,,,2663957,[],CHEMBL1023543,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818802,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
10985,,,2667047,[],CHEMBL1029495,Antibacterial activity against mucosa-associated Escherichia coli isolates isolated from patients with Crohn's disease by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,819948,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
10986,,,2667141,[],CHEMBL1032826,Cytotoxicity against mouse J774A1 cells assessed as release of adenylate kinase at 100 ug/ml after 3 hrs by total cell protein assay relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,819948,=,1,0,=,,Activity,%,,90.0,CHEMBL614040,Mus musculus,J774.A1,10090.0,,,Activity,%,UO_0000187,,90.0
10987,,,2667550,[],CHEMBL1032844,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820037,>,1,0,>,,Activity,ug ml-1,,64.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,64.0
10988,,,2667558,[],CHEMBL1032845,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by agar counting method,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820037,>,1,0,>,,Activity,ug ml-1,,64.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,64.0
10989,,,2667566,[],CHEMBL1032846,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as minimum drug level resulting in no detectable growth at 10'6 CFU of inoculum after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820037,>,1,0,>,,Activity,ug ml-1,,64.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,64.0
10990,,Not Evaluated,2667578,[],CHEMBL1032842,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at >10'2 CFU of inoculum by MGIT 960 susceptibility test,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,820037,,1,0,,,Activity,,,,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,,,,
10991,,Not Evaluated,2667586,[],CHEMBL1032843,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at 10'5 CFU of inoculum by MGIT 960 susceptibility test,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,820037,,1,0,,,Activity,,,,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,,,,
10992,,,2669298,[],CHEMBL1031143,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151908,Bioorg Med Chem Lett,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,821212,=,1,1,=,,MIC,nM,,100000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/L,UO_0000065,,100.0
10993,,,2669299,[],CHEMBL1031144,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151908,Bioorg Med Chem Lett,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,821212,=,1,1,=,,MIC,nM,,200000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,200.0
10994,,,2669300,[],CHEMBL1031145,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151908,Bioorg Med Chem Lett,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,821212,=,1,1,=,,MIC,nM,,200000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,200.0
10995,,,2669301,[],CHEMBL1031146,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151908,Bioorg Med Chem Lett,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,821212,=,1,1,=,,MIC,nM,,200000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,umol/L,UO_0000065,,200.0
10996,,,2669302,[],CHEMBL1031147,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1151908,Bioorg Med Chem Lett,2009.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,821212,=,1,1,=,,MIC,nM,,200000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/L,UO_0000065,,200.0
10997,,,2680921,[],CHEMBL1060597,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 46 harboring DNA gyrase A D87G mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823679,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,64.0
10998,,,2680922,[],CHEMBL1060590,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 102 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823679,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,128.0
10999,,,2680923,[],CHEMBL1060605,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT145 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823679,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,128.0
